<?xml version="1.0" encoding="utf-8"?>
<XML>
<JOURNAL>
<YEAR>2011</YEAR>
<VOL>9</VOL>
<NO>1</NO>
<MOSALSAL>0</MOSALSAL>
<PAGE_NO>0</PAGE_NO>


<ARTICLES>

	<ARTICLE> 
		<TitleF>Effects of Tyrode's solution osmolarities and milk on bull sperm storage above zero temperatures</TitleF>
		<TitleE>اثر اسمولاریتی های مختلف محلول تیرود و شیر بر ذخیره سازی اسپرم گاو در دماهای بالاتر از صفر درجه سانتی گراد
</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: کنترل اسمولاریتی و دمای محیط در طول دستکاری کوتاه مدت و بلند مدت اسپرم ضروری است.
هدف: اهداف مطالعه حاضر، یافتن تاثیر اسمولاریتی های مختلف محلول تیرود و شیر برای انکوباسیون اسپرم گاو در دماهای بالای صفر درجه سانتی گراد می باشد.
مواد و روش کار: جهت انجام آزمایشات از 5 رأس گاو نجدی خوزستان دو بار انزال تهیه گردید. نمونه ها سانتریفیوژ شده و بخش عمده مایع منوی خارج شد. آزمایش اول: انزال های غلیظ شده به 9 حجم مساوی تقسیم شدند و در محیط با سه اسمولاریتی مختلف (200، 300 و 400 میلی اسمول) در سه دما (5، 25 و 39 درجه سانتی گراد) به مدت 15 و 60 دقیقه مورد ارزیابی قرار گرفتند. آزمایش دوم: انزال غلظ شده به حجم های مساوی تقسیم شد و با حجم برابر شیر در دو دمای 5 و 25 درجه سانتی گراد و شیر به همراه 7 % گلیسرول در دمای 5 درجه سانتی گراد مخلوط و پس 15 و 60 دقیقه انکوباسیون مورد بررسی قرار گرفتند.
نتایج: اسمولاریتی کم و به خصوص در دمای پایین تحرک اسپرم را به شدت تحت تأثیر قرار داد (p&#60;0.05). افزایش دمای انکوباسیون اثرات مخرب اسمولاریتی پایین بر زنده مانی اسپرم را کاهش داد (p&#60;0.05). اما کاهش تحرک اسپرم ناشی از اسمولاریتی پایین با افزایش دمای محیط حتی تا ا ساعت انکوباسیون بهبود نیافت (p&#62;0.05). شیر زنده مانی و تحرک اسپرم را در دمای پایین محافظت نمود (p&#60;0.05) و افزودن گلیسرول به شیر اثر بهبود دهنده ای بر انکوباسیون اسپرم در دماهای بالای صفر درجه سانتی گراد نداشت (p&#62;0.05).
نتیجه گیری: محلول های ایزو و هیپر اسموتیک تحرک و زنده مانی اسپرم را دماهای 25 و 39 درجه سانتی گراد حفاظت می کنند و شیر در دمای 5 درجه سانتی گراد از اسپرم محافظت می نماید.
&#160;</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Control of the medium osmolarity and temperature during long or short time sperm manipulation is essential.
Objective: The objectives of the present study were to find the effects of different osmolarities of modified&#160;Tyrode&#39;s solution and milk on the bull sperm during incubation at above zero temperatures.
Materials and Methods: Semen samples were collected twice from five Najdi bull. Centrifuged and most parts of seminal plasma were removed. First experiment: The concentrated semen were splited into nine aliquots to incubate in three different osmolarities (200, 300 and 400 mOsm) at three temperatures (5, 25 and 39&#176;C) for 15 and 60 min of incubation. Second experiment: The semen samples were splited, mixed with the same volume of whole cow milk (5 and 25&#176;C) and milk with 7% glycerol (5&#176;C) and incubated for 15 and 60 min.
Results: Sperm motility severely affected (p&#60;0.05) by incubation at low ionic tension (200 mOsm/l) especially at low temperature (5&#176;C). The impact of low osmolarity on sperm viability can reduce by increasing the incubation temperature to 39&#176;C. The decreased sperm motility, which was induced by lowering osmolarity, was not improved (p&#62;0.05) by increasing temperature during 1 h of incubation. Milk can protect the sperm viability and motility at cool conditions and there is no beneficial effect of glycerol in combination of milk on sperm incubation at above zero temperatures (p&#60;0.05).
Conclusion: Iso- and hyper-osmotic solutions protect bull sperm motility and viability at 25 and 39&#176;C, while milk can be used for protecting sperm at 5&#176;C.&#160;</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>0</FPAGE>
			<TPAGE>0</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2017/10/1
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/7/9
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2017/10/5
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1396/7/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>فرید</Name>
				<MidName></MidName>
				<Family>براتی</Family>
				<NameE>Farid</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Barati</FamilyE>
				<Organizations>
				<Organization>Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>fabrtir@yahoo.com, baratif@scu.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>احمدعلی</Name>
				<MidName></MidName>
				<Family>پاپهن</Family>
				<NameE>Ahmad Ali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Papahn</FamilyE>
				<Organizations>
				<Organization>Department of Basic Sciences, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>مهسا</Name>
				<MidName></MidName>
				<Family>افروغ</Family>
				<NameE>Mahsa</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Afrough</FamilyE>
				<Organizations>
				<Organization>Department of Basic Sciences, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>محمد</Name>
				<MidName></MidName>
				<Family>براتی</Family>
				<NameE>Mohammad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Barati</FamilyE>
				<Organizations>
				<Organization>Department of Applied Chemistry, University of Tabriz, Tabriz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText> Bull sperm</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Tyrode's  solution</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Whole milk</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Osmolarity</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Glycerol</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>اسپرم گاو</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>محلول تیرود</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>شیر کامل</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>اسمولاریتی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>گلیسرول</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Gao DO, Mazur P, Critser JK. Fundamental cryobiology of mammalian spermatozoa, In: Karow AM, Critser JK. (Eds.). Reproductive tissue banking: scientific priniciples, San Diego, USA: Academic press; 1997: 263-328.##Morris GJ, Faszer K, Green JE, Draper D, Grout BWW, Fonseca F. Rapidly cooled horse spermatozoa: Loss of viability is due to osmotic imbalance during thawing, not intracellular ice formation. Theriogenology 2007; 68:804-812.##Niasari-Naslaji A, Mosaferi S, Bahmani N, Abarghani A, Gharahdaghi AA, Gerami A. Effect of lactose extender with different levels of osmolality and pH on the viability of Bactrian camel (Camelus bactrianus) spermatozoa. IJVR 2006; 7: 14-22.##Andrade AFCd, Celeghini ECC, Yonezawa LA, Spers A, Arruda RPd. In vitro efficiency of three extenders for rabbit semen. Braz J Vet Res Anim Sci 2008; 45: 33-39.##Rigby SL, Brinsko SP, Cochran M, Blanchard TL, Love CC, Varner DD. Advances in cooled semen technologies: seminal plasma and semen extender. Anim Reprod Sci 2001;68: 171-180.##Agca Y, Gilmore J, Byers M, Woods EJ, Liu J, Critser JK. Osmotic characteristics of mouse spermatozoa in the presence of extenders and sugars. Biol Reprod 2002; 67:1493-1501.##Liu ZS, Foote RH. Osmotic effects on volume and motility of bull sperm exposed to membrane permeable and nonpermeable agents. Cryobiology 1998; 37:207-218.##Waterhouse KE, Gjeldnes A, Tverdal A, De Angelis PM, Farstad W, Haard M, Kommisrud E. Alterations of sperm DNA integrity during cryo preservation procedure and in vitro incubation of bull semen. Anim Reprod Sci 2010; 117: 34-42.##Pommer AC, Rutllant J, Meyers SA. The role of osmotic resistance on equine spermatozoal function. Theriogenology 2002; 58: 1373-1384.##Chaveiro A, Liu J, Engel B, Critser JK, Woelders H. Significant variability among bulls in the sperm membrane permeability for water and glycerol: Possible implications for semen freezing protocols for individual males. Cryobiology 2006; 53:349-359.##Varisli O, Uguz C, Agca C, Agca Y. Motility and acrosomal integrity comparisons between electro-ejaculated and epididymal ram sperm after exposure to a range of anisosmotic solutions, cryoprotective agents and low temperatures. Anim Reprod Sci 2009; 110: 256-268.##Zhao YY, Buhr MM. Cryopreservation extenders affect calcium flux in bovine spermatozoa during a temperature challenge. J Androl 1995; 16: 278-285.##Vishwanath R, Shannon P. Storage of bovine semen in liquid and frozen state. Anim Reprod Sci 2000; 62: 23-53.##Cooper TG, Hellenkemper B. Method-Related Estimates of Sperm Vitality. J Androl 2009; 30: 214-218.##SAS. SAS/STAT User's Guide. Release 6.03 Edn., Statistical Analysis Systems Institute, Inc., Cary, NC.; 1996: 550-641.##Brackett BG, Oliphant G. Capacitation of rabbit spermatozoa in vitro. Biol Reprod 1975; 12:260-274.##Webb GW, Arns MJ. Influence of modified Tyrode's media on motility of cold-stored stallion spermatozoa. J Equine Vet Sci 1995; 15: 441-444.##Parks JE. Hypothermia and mammalian gametes. In: Karow AM, Critser JK. (Eds.). Reproductive tissue banking: scientific principles, San Diego, USA: Academic press; 1997: 229-247.##Batellier F, Vidament M, Fauquant J, Duchamp G, Arnaud G, Yvon JM, Magistrini M. Advances in cooled semen technology. Anim Reprod Sci 2001; 68: 181-190.##Ball BA. Oxidative stress, osmotic stress and apoptosis: Impacts on sperm function and preservation in the horse. Anim Reprod Sci 2008; 107:257-267.##Zhang BR, Buhr M, Kroetsch T, Leibo SP. Glycine betaine improves survival of fresh bovine spermatozoa. Reproduction Fertility Dev 2001; 13: 187-192.##Zhou JB, Yue KZ, Luo MJ, Chang ZL, Liang H, Wang ZY, Tan JH. Effect of extenders and temperatures on sperm viability and fertilizing capacity of Harbin white boar semen during long-term liquid storage. AJAS 2004; 17: 1501-1508.##Li G, Saenz J, Godke RA, Devireddy RV. Effect of glycerol and cholesterol-loaded cyclodextrin on freezing-induced water loss in bovine spermatozoa. Reproduction 2006; 131: 875-886.##Van Thuan N, Wakayama S, Kishigami S, Wakayama T. New preservation method for mouse spermatozoa without freezing. Biol Reprod 2005; 72: 444-450.##Gao DO, Mazur P, Critser JK. Fundamental cryobiology of mammalian spermatozoa, In: Karow AM, Critser JK. (Eds.). Reproductive tissue banking: scientific priniciples, San Diego, USA: Academic press; 1997: 263-328.##Morris GJ, Faszer K, Green JE, Draper D, Grout BWW, Fonseca F. Rapidly cooled horse spermatozoa: Loss of viability is due to osmotic imbalance during thawing, not intracellular ice formation. Theriogenology 2007; 68:804-812.##Niasari-Naslaji A, Mosaferi S, Bahmani N, Abarghani A, Gharahdaghi AA, Gerami A. Effect of lactose extender with different levels of osmolality and pH on the viability of Bactrian camel (Camelus bactrianus) spermatozoa. IJVR 2006; 7: 14-22.##Andrade AFCd, Celeghini ECC, Yonezawa LA, Spers A, Arruda RPd. In vitro efficiency of three extenders for rabbit semen. Braz J Vet Res Anim Sci 2008; 45: 33-39.##Rigby SL, Brinsko SP, Cochran M, Blanchard TL, Love CC, Varner DD. Advances in cooled semen technologies: seminal plasma and semen extender. Anim Reprod Sci 2001;68: 171-180.##Agca Y, Gilmore J, Byers M, Woods EJ, Liu J, Critser JK. Osmotic characteristics of mouse spermatozoa in the presence of extenders and sugars. Biol Reprod 2002; 67:1493-1501.##Liu ZS, Foote RH. Osmotic effects on volume and motility of bull sperm exposed to membrane permeable and nonpermeable agents. Cryobiology 1998; 37:207-218.##Waterhouse KE, Gjeldnes A, Tverdal A, De Angelis PM, Farstad W, Haard M, Kommisrud E. Alterations of sperm DNA integrity during cryo preservation procedure and in vitro incubation of bull semen. Anim Reprod Sci 2010; 117: 34-42.##Pommer AC, Rutllant J, Meyers SA. The role of osmotic resistance on equine spermatozoal function. Theriogenology 2002; 58: 1373-1384.##Chaveiro A, Liu J, Engel B, Critser JK, Woelders H. Significant variability among bulls in the sperm membrane permeability for water and glycerol: Possible implications for semen freezing protocols for individual males. Cryobiology 2006; 53:349-359.##Varisli O, Uguz C, Agca C, Agca Y. Motility and acrosomal integrity comparisons between electro-ejaculated and epididymal ram sperm after exposure to a range of anisosmotic solutions, cryoprotective agents and low temperatures. Anim Reprod Sci 2009; 110: 256-268.##Zhao YY, Buhr MM. Cryopreservation extenders affect calcium flux in bovine spermatozoa during a temperature challenge. J Androl 1995; 16: 278-285.##Vishwanath R, Shannon P. Storage of bovine semen in liquid and frozen state. Anim Reprod Sci 2000; 62: 23-53.##Cooper TG, Hellenkemper B. Method-Related Estimates of Sperm Vitality. J Androl 2009; 30: 214-218.##SAS. SAS/STAT User's Guide. Release 6.03 Edn., Statistical Analysis Systems Institute, Inc., Cary, NC.; 1996: 550-641.##Brackett BG, Oliphant G. Capacitation of rabbit spermatozoa in vitro. Biol Reprod 1975; 12:260-274.##Webb GW, Arns MJ. Influence of modified Tyrode's media on motility of cold-stored stallion spermatozoa. J Equine Vet Sci 1995; 15: 441-444.##Parks JE. Hypothermia and mammalian gametes. In: Karow AM, Critser JK. (Eds.). Reproductive tissue banking: scientific principles, San Diego, USA: Academic press; 1997: 229-247.##Batellier F, Vidament M, Fauquant J, Duchamp G, Arnaud G, Yvon JM, Magistrini M. Advances in cooled semen technology. Anim Reprod Sci 2001; 68: 181-190.##Ball BA. Oxidative stress, osmotic stress and apoptosis: Impacts on sperm function and preservation in the horse. Anim Reprod Sci 2008; 107:257-267.##Zhang BR, Buhr M, Kroetsch T, Leibo SP. Glycine betaine improves survival of fresh bovine spermatozoa. Reproduction Fertility Dev 2001; 13: 187-192.##Zhou JB, Yue KZ, Luo MJ, Chang ZL, Liang H, Wang ZY, Tan JH. Effect of extenders and temperatures on sperm viability and fertilizing capacity of Harbin white boar semen during long-term liquid storage. AJAS 2004; 17: 1501-1508.##Li G, Saenz J, Godke RA, Devireddy RV. Effect of glycerol and cholesterol-loaded cyclodextrin on freezing-induced water loss in bovine spermatozoa. Reproduction 2006; 131: 875-886.##Van Thuan N, Wakayama S, Kishigami S, Wakayama T. New preservation method for mouse spermatozoa without freezing. Biol Reprod 2005; 72: 444-450.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Infertility in Mazandaran province - north of Iran: an etiological study</TitleF>
		<TitleE>بررسی اتیولوژیک ناباروری در مازندران – شمال ایران </TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: شیوع ناباروری و نیز توزیع علل مختلف آن در میان جمعیت زوج های نابارور در نواحی مختلف دنیا متفاوت می باشد. در خصوص بررسی علل مختلف ناباروری مطالعات انجام شده در ایران محدود هستند.
هدف: این مطالعه به منظور مشخص کردن علل اصلی ناباروری در بیماران نابارور منطقه مازندران و تعیین نسبت هر یک از علت ها انجام شده است.
مواد و روش ها: در این مطالعه توصیفی، پرونده پزشکی 3734 زوج نابارور مراجعه کننده به دو کلینیک اصلی ناباروری استان مازندران، طی سال های 1380 تا 1385 مورد بررسی قرار گرفت. در این مطالعه افراد نابارور کسانی در نظر گرفته شدند که پس از یک سال زناشویی بدون پیشگیری بچه دار نشده بودند.
یافته ها: از کل جمعیت نابارور مورد مطالعه، 78/7 درصد نازایی اولیه و 3/21 درصد نازایی ثانویه داشتند. میانگین دوره ناباروری پیش از اولین مراجعه به یک کلینیک ناباروری 4 &#177;5/7 سال بوده است. تعیین علل ناباروری در بیماران نشان داد که 38/9 درصد نازایی ها، بدلیل علل مردانه، 34/7 درصد به علل زنانه و در 14/6 درصد، هر دو زوج درگیر بودند. در 11/8 درصد موارد هم علت ناباروری شناخته نشد.
نتیجه گیری: در این مطالعه، تاخیر زمانی قابل توجه ای در مراجعه زوج های نابارور به یک کلینیک ناباروری دیده می شود. بدین ترتیب بنظر می رسد برنامه آموزش بهداشت باروری و آگاهی دادن در خصوص فاکتورهای خطر از جمله تاخیر در درمان نازایی و راههای پیشگیری از وقوع احتمالی مشکلات باروری، باید مورد توجه بیشتری قرار گیرند.
&#160;</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: The prevalence and etiology of infertility are not similar in different parts of the world. There are only few reports of this topic in Iran.
Objective: This study was conducted to determine the clinical patterns and major causes of infertility in Mazandaran province in north of Iran.
Materials and Methods: The medical records of 3734 consecutive couples attending two infertility clinics in Mazandaran province, from 2003 to 2008, were reviewed. The couples had not had a viable birth after at least 1 year of unprotected intercourse and were fully investigated.
Results: Of the entire samples, 78.7% had primary infertility and 21.3% had secondary infertility. The mean duration of infertility in couples was 5.7&#177;4 years. The etiology of infertility in couples revealed; male factor in 38.9%, female factor in 34.7%, combined factors in 14.6% and undetermined cause in 11.8%.
Conclusion: In this study, delayed attendance of infertile couples to the infertility clinic was found. Therefore, there is a need to revise public health program on infertility to focus on the education and prevention of infertility and its risk factors.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>0</FPAGE>
			<TPAGE>0</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2017/10/12017/10/1
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/7/9
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2017/10/52017/10/5
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1396/7/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>عباسعلی</Name>
				<MidName></MidName>
				<Family>کریم پور ملکشاه</Family>
				<NameE>Abbasali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Karimpour Malekshah</FamilyE>
				<Organizations>
				<Organization>Department of Embryology, Cellular and Molecular Center,  Imam University Hospital, Infertility Center, Mazandaran University of Medical Sciences, Sari, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>امیر</Name>
				<MidName></MidName>
				<Family>اسماعیل نژاد مقدم</Family>
				<NameE>Amir</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Esmailnejad Moghaddam</FamilyE>
				<Organizations>
				<Organization>Department of Embryology, Infertility Center, Imam University Hospital, Mazandaran University of Medical Sciences, Sari, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>نرگس</Name>
				<MidName></MidName>
				<Family>مسلمی زاده</Family>
				<NameE>Narges</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Moslemizadeh</FamilyE>
				<Organizations>
				<Organization>Department of Obstetrics and Gynecology, Infertility Center, Imam University Hospital, Mazandaran University of Medical Sciences, Sari, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>سپیده</Name>
				<MidName></MidName>
				<Family>پیوندی</Family>
				<NameE>Sepideh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Peivandi</FamilyE>
				<Organizations>
				<Organization>Department of Obstetrics and Gynecology, Infertility Center, Imam University Hospital, Mazandaran University of Medical Sciences, Sari, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>ایوب</Name>
				<MidName></MidName>
				<Family>برزگرنژاد</Family>
				<NameE>Ayyub</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Barzegarnejad</FamilyE>
				<Organizations>
				<Organization>Department of Urology, Infertility Center, Imam University Hospital, Mazandaran University of Medical Sciences, Sari, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>ayubbarzgarnejad@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>نادعلی</Name>
				<MidName></MidName>
				<Family>موسی نژاد</Family>
				<NameE>Nadali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Musanejad</FamilyE>
				<Organizations>
				<Organization>Department of Urology, Infertility Center, Imam University Hospital, Mazandaran University of Medical Sciences, Sari, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>غلامعلی</Name>
				<MidName></MidName>
				<Family>جورسرایی</Family>
				<NameE>Gholamali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Jursarayee</FamilyE>
				<Organizations>
				<Organization>Department of Embryology, Fatemeh Zahra Infertility Center, Babol University of Medical Sciences, Babol, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Primary infertility</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Secondary infertility</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Male factor</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Ovarian dysfunction</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Varicocel</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ناباروری اولیه</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ناباروری ثانویه</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>فاکتورهای مردانه</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>نارسایی تخمدان</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>واریکوسل</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>World Health Organization. Infertility: A tabulation of available data on prevalence of primary and secondary infertility, Geneva: WHO program on maternal and child health and family planning, division of family health, 1991.##Kds A, Nguyen T. Infertility in developing countries. Reproductive Health Outlook 1997; 15: 1-14.##Moghaddam A, Karimpour Malekshah A, Talebpour Amiri F, Taringou F. The prevalence of infertility in center region of Mazandaran province in 1999. Journal of Mazandaran University of Medical Sciences 2000; 10:12-18.##Vahidi S, Ardalan A, Kazem m. The epidemiology of primary infertility in the Islamic republic of iran in 2004-2005. Journal of Reproduction and Infertility 2006; 7: 243-251.##Leke RJ, Bassol-Mayagoitia S. Bacha AM, Grigor KM. Regional and geographical variation in infertility: effects of environmental, cultural and socioeconomic factors. Environ Health Perspect 1993; 101: 73-80.##Terava AN, Gissler M, Hemminiki E, Luoto R. Infertility and the use of infertility treatments in Finland: prevalence and socio-demographic determinants 1992-2004. Eur J Obstet Gynecol Reprod Biol 2008; 136: 61-66.##Wyshak G. Infertility in Americian college alumnae. International Journal of Gynecol Obstet 2001; 73: 237-242.##Aflatoonian A, Seyedhassani SM, Tabibnejad N. The epidemiological and etiological aspect of infertility inYazd province of Iran. Iranian Journal of Reproductive Medicine 2009; 7: 117-122.##Safarinejad M. Infertility among couples in a population-based study in Iran: prevalence and associated risk factors. Int J Androl 2008; 31: 303-314.##World Health Organization. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction, 4th edition, Cambridge: Cambridge university press, 1999.##Esmeilzadeh S, Farsi M, Nazari T.The cause of infertility in the patients referring to Babol township fatemeh Zahra infertility center from May 1996 to May 1998. Journal of Mazandaran University of Medical Sciences 2002; 12: 29-33.##Kamali M, Kashfi F, Baghestani AR, Kashani H, Tavajohi SH, Amirchaghmaghi E. The epidemiologic survey on causes of infertility in patients refered to Royan institute. Medical Journal of Tabriz University of Medical Sciences 2006; 28: 103-105.##Cates W, Farley TMM, Rowe PJ. Worldwide patterns of infertility. Is Africa different? Lancet 1985; 2: 596-598.##Orhue A, Aziken M. Experience with a comprehensive university hospital-based infertility program in Nigeria. Int J Gynaecol Obstet 2008; 101: 11-15.##Bayasgalan G, Naranbat D, Tsedmaa B, Tsogmaa B, Sukhee D, Amarjargal O, Lhagvasuren T, Radnaabazar J, Rowe PJ. Clinical patterns and major causes of infertility in Mongolia. J Obstet Gynaecol Res 2004; 30: 386-394.##World health organization. Infections, pregnancies and infertility: Perspectives on prevention. Fertil Steril 1987; 47: 964-968.##Zargar AH, Wani AI, Masoodi SR, Laway BA, Salahuddin M. Epidemiologic and aspects of primary infertility in the Kashmir region of India. Fertil Steril 1997; 68: 637-643.##Omu AE, Ismail AA, AL-Qattan F. Infertility in Kuwait. Int J Gynaecol Obstet 1999; 67: 113-114.##Cates W, Farley TM, Rowe PJ. Patterns of infertility in the developed and developing world. in: Rowe PJ, Vikhlaeva EM (eds) WHO symposium on diagnosis and treatment of infertility, Yerevan, Armenia Toronto: Han,s Huber publisher, 1988: 57-67.##Isaksson R, Tiitinen A. Present concept of unexplained infertility. Gynaecol Endocrionol 2004: 18: 278-290.##Forti G, Krausz C. Evaluation and treatment of the infertile couple. Clin Endocrinol Metabol 1998; 83: 4177-4188.##Thonneau P, Marchand S, Tallec A, Ferial ML, Ducot B, Lansac J, et al. Incidence and main causes of infertility in a resident population (1,850,000) of three Franch regions (1988-1989). Hum Reprod 1991; 6: 811-816.##Hull MG, Glazener CM, Kelly NJ, Conway DI, Foster PA, Hinton RA, Coulson C, Lambert PA, Watt EM, Desai KM. Population study of causes, treatment and outcome of infertility. Br Med J (Clin Res Ed) 1985; 291: 1693-1697.##Rahim R, Majid SS. Aetiological factors of infertility. JPMI 2004; 18: 166-171.##Philippov OS, Radionchenko AA, Bolotova VP, Voronovskaya NI, Potemkina TV. Estimation of the prevalence and causes of infertility in western Siberia. Bull World Health Organ 1998; 76: 183-187.##Inhorn Mc, Buss KA. Ethnography epidermiology and infertility in Egypt. Social Science and Medicine1994; 39: 671-686.##Ericksen K, Brunette T. Patterns and predictors of infertility among African women: A cross-national survey of twenty seven nations. Social Science and Medicine 1996; 42: 209-220.##World Health Organization. Infertility: A tabulation of available data on prevalence of primary and secondary infertility, Geneva: WHO program on maternal and child health and family planning, division of family health, 1991.##Kds A, Nguyen T. Infertility in developing countries. Reproductive Health Outlook 1997; 15: 1-14.##Moghaddam A, Karimpour Malekshah A, Talebpour Amiri F, Taringou F. The prevalence of infertility in center region of Mazandaran province in 1999. Journal of Mazandaran University of Medical Sciences 2000; 10:12-18.##Vahidi S, Ardalan A, Kazem m. The epidemiology of primary infertility in the Islamic republic of iran in 2004-2005. Journal of Reproduction and Infertility 2006; 7: 243-251.##Leke RJ, Bassol-Mayagoitia S. Bacha AM, Grigor KM. Regional and geographical variation in infertility: effects of environmental, cultural and socioeconomic factors. Environ Health Perspect 1993; 101: 73-80.##Terava AN, Gissler M, Hemminiki E, Luoto R. Infertility and the use of infertility treatments in Finland: prevalence and socio-demographic determinants 1992-2004. Eur J Obstet Gynecol Reprod Biol 2008; 136: 61-66.##Wyshak G. Infertility in Americian college alumnae. International Journal of Gynecol Obstet 2001; 73: 237-242.##Aflatoonian A, Seyedhassani SM, Tabibnejad N. The epidemiological and etiological aspect of infertility inYazd province of Iran. Iranian Journal of Reproductive Medicine 2009; 7: 117-122.##Safarinejad M. Infertility among couples in a population-based study in Iran: prevalence and associated risk factors. Int J Androl 2008; 31: 303-314.##World Health Organization. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction, 4th edition, Cambridge: Cambridge university press, 1999.##Esmeilzadeh S, Farsi M, Nazari T.The cause of infertility in the patients referring to Babol township fatemeh Zahra infertility center from May 1996 to May 1998. Journal of Mazandaran University of Medical Sciences 2002; 12: 29-33.##Kamali M, Kashfi F, Baghestani AR, Kashani H, Tavajohi SH, Amirchaghmaghi E. The epidemiologic survey on causes of infertility in patients refered to Royan institute. Medical Journal of Tabriz University of Medical Sciences 2006; 28: 103-105.##Cates W, Farley TMM, Rowe PJ. Worldwide patterns of infertility. Is Africa different? Lancet 1985; 2: 596-598.##Orhue A, Aziken M. Experience with a comprehensive university hospital-based infertility program in Nigeria. Int J Gynaecol Obstet 2008; 101: 11-15.##Bayasgalan G, Naranbat D, Tsedmaa B, Tsogmaa B, Sukhee D, Amarjargal O, Lhagvasuren T, Radnaabazar J, Rowe PJ. Clinical patterns and major causes of infertility in Mongolia. J Obstet Gynaecol Res 2004; 30: 386-394.##World health organization. Infections, pregnancies and infertility: Perspectives on prevention. Fertil Steril 1987; 47: 964-968.##Zargar AH, Wani AI, Masoodi SR, Laway BA, Salahuddin M. Epidemiologic and aspects of primary infertility in the Kashmir region of India. Fertil Steril 1997; 68: 637-643.##Omu AE, Ismail AA, AL-Qattan F. Infertility in Kuwait. Int J Gynaecol Obstet 1999; 67: 113-114.##Cates W, Farley TM, Rowe PJ. Patterns of infertility in the developed and developing world. in: Rowe PJ, Vikhlaeva EM (eds) WHO symposium on diagnosis and treatment of infertility, Yerevan, Armenia Toronto: Han,s Huber publisher, 1988: 57-67.##Isaksson R, Tiitinen A. Present concept of unexplained infertility. Gynaecol Endocrionol 2004: 18: 278-290.##Forti G, Krausz C. Evaluation and treatment of the infertile couple. Clin Endocrinol Metabol 1998; 83: 4177-4188.##Thonneau P, Marchand S, Tallec A, Ferial ML, Ducot B, Lansac J, et al. Incidence and main causes of infertility in a resident population (1,850,000) of three Franch regions (1988-1989). Hum Reprod 1991; 6: 811-816.##Hull MG, Glazener CM, Kelly NJ, Conway DI, Foster PA, Hinton RA, Coulson C, Lambert PA, Watt EM, Desai KM. Population study of causes, treatment and outcome of infertility. Br Med J (Clin Res Ed) 1985; 291: 1693-1697.##Rahim R, Majid SS. Aetiological factors of infertility. JPMI 2004; 18: 166-171.##Philippov OS, Radionchenko AA, Bolotova VP, Voronovskaya NI, Potemkina TV. Estimation of the prevalence and causes of infertility in western Siberia. Bull World Health Organ 1998; 76: 183-187.##Inhorn Mc, Buss KA. Ethnography epidermiology and infertility in Egypt. Social Science and Medicine1994; 39: 671-686.##Ericksen K, Brunette T. Patterns and predictors of infertility among African women: A cross-national survey of twenty seven nations. Social Science and Medicine 1996; 42: 209-220.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Controlled ovarian hyperstimulation and intrauterine insemination cycles in patients with unilateral tubal blockage diagnosed by hysterosalpingography</TitleF>
		<TitleE>انجام تحریک کنترل شده تخمدانی  و تزریق درون رحمی نطفه در بیماران مبتلا به انسداد یک طرفه لوله رحمی تشخیص داده شده با هیستروسالپنگوگرافی </TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: تحریک کنترل شده تخمدانی همراه با&#160; تزریق درون رحمی نطفه یک برنامه درمانی مناسب برای برخی از بیماران نابارور میباشد. بنابراین ما تصمیم گرفتیم که &#160;این برنامه درمانی را در درمان بیمارانی که بسته بودن یک طرفه لوله رحمی آنها توسط هیستروسالپنگوگرافی نشان داده شده است، امتحان نمائیم. &#160;
هدف: بررسی تاثیر بسته بودن یک طرفه لوله رحمی (نشان داده شده توسط هیستروسالپنگوگرافی)&#160; بر روی میزان تجمعی حاملگی در سیکل های تحریک شده تزریق درون رحمی نطفه.
مواد و روش ها: این تحقیق یک مطالعه مقطعی- موردی است که از مهر ماه 1385 تا مهرماه&#160; 1388، در یک مرکز دانشگاهی ناباروری انجام شده است. دو گروه بیمار مورد بررسی قرار گرفته اند. در گروه مطالعه 64 زوج با تشخیص بسته بودن یک طرفه لوله رحمی، و در گروه شاهد&#160; 200 زوج با تشخیص نازایی با عامل ناشناخته قرار گرفتند. &#160;سه سیکل تحریک شده ( کلومیفن سیترات و (hMG به همراه تزریق درون رحمی نطفه دراین بیماران انجام و میزان تجمعی حاملگی در این دو گروه مقایسه گردید.
نتایج: مشخصات دموگرافیک گروه ها یکسان می باشد. میزان حاملگی در گروه مطالعه(26/6%) و در گروه شاهد&#160; ( 28%) بود&#160; که ازنظر آماری تفاوت معنی داری بین دو گروه مشاهده نگردید

&#160;p=0.87; OR=1.075; 95% CI: 0.57 -2.28) &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;
بحث: بسته بودن یک طرفه لوله ها که&#160; توسط هیستروسالپنگوگرافی نشان داده شده است، اثری بر روی میزان موفقیت سیکل های تحریک شده همراه با تزریق داخل رحمی نطفه ندارد. بنابرین سیکل های تحریک شده همراه با تزریق داخل رحمی نطفه را می توان به عنوان اولین اقدام درمانی در این گروه بیماران نابارورپیشنهادکرد.&#160;&#160;</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>&#160;Background: Controlled ovarian hyperstimulation and intrauterine insemination (IUI) cycle is an ideal protocol for some subfertile patients. So, we decided to try this therapeutic protocol for the patients with unilateral tubal blockage diagnosed by hysterosalpingography (HSG).&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Objective: To evaluate the effect of unilateral tubal blockage diagnosed by HSG on cumulative pregnancy rate (CPR) of the stimulated IUI cycles.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Materials and Methods: A cross-sectional analysis was performed between October 2006 and October 2009 in an academic reproductive endocrinology and infertility center. Two groups of patients undergoing stimulated IUI cycles were compared. Sixty-four infertile couples with unilateral tubal blockage diagnosed by HSG as the sole cause of infertility in the group (І), and two hundred couples with unexplained infertility in the group (II). The patients underwent 3 consecutive ovarian hyperstimulation (Clomiphen citrate and human menopausal gonadotropin) and IUI cycles. The main outcome measurements were the CPRs per patients for 3 consecutive stimulated IUI cycles.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Results: Cycle characteristics were found to be homogenous between the both groups. CPRs were similar in group І (26.6%) and group II (28%) (p=0.87; OR=1.075; 95% CI: 0.57 -2.28).
Conclusion: Unilateral tubal blockage (diagnosed on HSG) has no effect on success rate of stimulated IUI cycles, so COH and IUI could be recommended as the initial therapeutic protocol in these patients.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>0</FPAGE>
			<TPAGE>0</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2017/10/12017/10/12017/10/1
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/7/9
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2017/10/52017/10/52017/10/5
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1396/7/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>مهبد</Name>
				<MidName></MidName>
				<Family>ابراهیمی</Family>
				<NameE>Mahbod</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ebrahimi</FamilyE>
				<Organizations>
				<Organization>Department of Obstetrics and Gynecology, Mirza Koochak Khan Hospital, Faculty of Medicine, Tehran University of Medical Sciences, Tehran , Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Maeb214@Yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>فیروزه</Name>
				<MidName></MidName>
				<Family>اکبری اسبق</Family>
				<NameE>Firoozeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Akbari Asbagh</FamilyE>
				<Organizations>
				<Organization>Department of Obstetrics and Gynecology, Mirza Koochak Khan Hospital, Faculty of Medicine, Tehran University of Medical Sciences, Tehran , Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>عزیزه</Name>
				<MidName></MidName>
				<Family>قاسمی نژاد</Family>
				<NameE>Azizeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghaseminejad</FamilyE>
				<Organizations>
				<Organization>Department of Obstetrics and Gynecology, Mirza Koochak Khan Hospital, Faculty of Medicine, Tehran University of Medical Sciences, Tehran , Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Hysterosalpingography</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Intrauterine insemination</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Ovarian hyperstimulation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>هیستروسالپنگوگرافی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تزریق درون رحمی نطفه</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تحریک تخمدانی</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Evert JL. Female subfertility, Lancet 2002; 360:151-159.##National Institue for Clinical Excellence. Fertility: Assessment and Treatment for People with Fertility problem. Full Guideline 2002, RCOG press, London.##Cheong YC, Li TC, Evidence-based management of tubal disease and infertility. Current Obstet Gynecol 2005; 15: 306-313.##Mol BW, Collin JA, Van Der Veen F, Bossuryt PM. Cost-effectiveness of hysterosalpingography, laparoscopy and Chlamydia antibodies testing in subfertile couples. Fertil Steril 2001; 75: 571-580.##Swart P, Mol BW, Van der veen F. The accuracy of hysterosalpingography and diagnosis of tubal pathology: a meta-analysis, Fertil Steril 1995, 64: 486-891.##Feyez JA, Mutie G, Schneider PJ. The diagnostic value of hysterosalpingography and laparoscopy in infertility investigation.Int J Fertil 1988; 33: 98-101.##Hutchins CJ, Laparoscopy and hysterosalpingography in the assessment of tubal patency. Obstet Gynecol 1997; 49:325-327.##Karasick S, Goldfarb AF. Peritubal adhesion in infertile women: diagnosis with hysterosalpingography. Am J Rentgenol 1989; 152:777-779.##Tanahatoe S, Lambalk CB, Hompes PGA. The role of laparoscopy in intrauterine insemination: a prospective randomized reallocation study. Hum Reprod 2005; 20: 3225-3230.##Lavy Y, Lev-sagie A, Holtzer H, Revel A, Hurwitz A. Should laparoscopy be a mandatory component of the infertility evaluation in infertile women with normal hysterosalpingography or suspected unilateral tubal pathology? European J OB &#59;GYN 2004; 114:64-68.##Fatum M, Laufer N, Simon A. Should diagnostic laparoscopy be performed after normal hysteroscopy in treating infertility suspected to be unknown origin? Hum Reprod 2002; 17:1-3.##The ESHRE Capri Workshop Group. Optimal use of infertility diagnostic tests and treatment. Hum Reprod 2000; 15: 723-732.##Honore GM, Holden AEC, Schenken RS, Pathophysiology and management of proximal tubal blockage. Fertil Steril 1999; 71: 785-795.##Papaioannou S, A hypothesis for the pathogenesis and natural history of proximal tubal blockage. Hum Reprod 2004; 19: 481-485.##Dchaud H, Reyftmann L, Faidherbe J, Hamamah S, Hedon B. Evidence-based reproductive surgery: tubal infertility . International Congress Series 2004; 1266: 96-100.##Coppus SFPG, Steures P, Van der steeg JW, Hompes PG A, Van der veen F, Mol BWJ. Unilateral tubal pathology on hysterosalpingography or diagnostic laparoscopy does not have prognostic significance for treatment – independent pregnancy at 12 months follow-up. Fertil Steril 2007; 88:s191.##Mol BWJ, Swart P, Bossuyt P, Van der veen F. Is hysterosalpingography an important tool in predicting fertility outcome? Fertil Steril 1997:67; 663-669.##Nordenskjold F, Ahlgren M. Laparoscopy in female infertility. Acta Obstet Gynecol Scand 1983; 62: 609-615.##Farhi J, Ben-Haroush A, Lande Y, Fish B. Role of treatment with ovarian stimulation and intrauterine insemination in women with unilateral tubal occlusion diagnosed by hysterosalpingography. Fertil Steril 2007; 88:396-400.##World Health Organization, Laboratory manual of the examination of human semen and sperm-mucus interaction, Cambridge, University Press, Cambridge, U.K; 1992.##American Fertility Society. Intervention of the infertile couple. Birmingham, AL: American Fertility Society; 1992##Rowe PJ, Comhaire FA, Hargreave TB, Mahmoud AMA. WHO, Manual for the standardized investigation of infertile couples. Cambridge, U K, Cambridge University, Press; 1993.##Chapron C, Querieu D, Bruhat MA, Madelenat P, Frenandez H, Pierre F, Dubuisson JB, Surgical complications of diagnostic and operative gynecological laparoscopy: a series of 29966 cases. Hum Reprod 1998; 13:867-872.##Gutmann JN, Emaging in the evaluation of female infertility. J Reprod Med 1992; 37; 54-61.##Parazzini F, Ablation of lesions or no treatment in minimal-mild endometriosis in infertile women: a randomized trial. Hum Reprod 1999; 14: 1332-1334.##Marcoux S, Maheux R, Berube S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis. N Engl J Med 1997; 337:217-222.##Simon A, Laufer N. Unexplained infertility: a reappraisal. Ass Reprod Rev 1993; 3: 3026-36.##Mol BW, Dijkman B, Wertheim P, Lijmer J, Van der veen F, Bossuy PM, The accuracy of serum Chlamydia antibodies in the diagnosis of tubal pathology: a meta-analysis . Fertil Steril 1997; 67: 1031-1037.##Mol B W, Collins J A, BurrowEA, Van der veen F, Bossoyt P M. Comprison of hysterosalpingography and laparoscopy in predicting fertility outcome. Hum Reprod 1999; 14: 1237-1242.##Dessole S, Battista G, Capobianco G, Menzoni MA, Ambrosini G, Canalis GC. A second hysterosalpingography reduce the use of selective technique for treatment of a proximal tubal obstruction. Fertil Steril 2000; 73: 1037-1039.##Evert JL. Female subfertility, Lancet 2002; 360:151-159.##National Institue for Clinical Excellence. Fertility: Assessment and Treatment for People with Fertility problem. Full Guideline 2002, RCOG press, London.##Cheong YC, Li TC, Evidence-based management of tubal disease and infertility. Current Obstet Gynecol 2005; 15: 306-313.##Mol BW, Collin JA, Van Der Veen F, Bossuryt PM. Cost-effectiveness of hysterosalpingography, laparoscopy and Chlamydia antibodies testing in subfertile couples. Fertil Steril 2001; 75: 571-580.##Swart P, Mol BW, Van der veen F. The accuracy of hysterosalpingography and diagnosis of tubal pathology: a meta-analysis, Fertil Steril 1995, 64: 486-891.##Feyez JA, Mutie G, Schneider PJ. The diagnostic value of hysterosalpingography and laparoscopy in infertility investigation.Int J Fertil 1988; 33: 98-101.##Hutchins CJ, Laparoscopy and hysterosalpingography in the assessment of tubal patency. Obstet Gynecol 1997; 49:325-327.##Karasick S, Goldfarb AF. Peritubal adhesion in infertile women: diagnosis with hysterosalpingography. Am J Rentgenol 1989; 152:777-779.##Tanahatoe S, Lambalk CB, Hompes PGA. The role of laparoscopy in intrauterine insemination: a prospective randomized reallocation study. Hum Reprod 2005; 20: 3225-3230.##Lavy Y, Lev-sagie A, Holtzer H, Revel A, Hurwitz A. Should laparoscopy be a mandatory component of the infertility evaluation in infertile women with normal hysterosalpingography or suspected unilateral tubal pathology? European J OB &#59;GYN 2004; 114:64-68.##Fatum M, Laufer N, Simon A. Should diagnostic laparoscopy be performed after normal hysteroscopy in treating infertility suspected to be unknown origin? Hum Reprod 2002; 17:1-3.##The ESHRE Capri Workshop Group. Optimal use of infertility diagnostic tests and treatment. Hum Reprod 2000; 15: 723-732.##Honore GM, Holden AEC, Schenken RS, Pathophysiology and management of proximal tubal blockage. Fertil Steril 1999; 71: 785-795.##Papaioannou S, A hypothesis for the pathogenesis and natural history of proximal tubal blockage. Hum Reprod 2004; 19: 481-485.##Dchaud H, Reyftmann L, Faidherbe J, Hamamah S, Hedon B. Evidence-based reproductive surgery: tubal infertility . International Congress Series 2004; 1266: 96-100.##Coppus SFPG, Steures P, Van der steeg JW, Hompes PG A, Van der veen F, Mol BWJ. Unilateral tubal pathology on hysterosalpingography or diagnostic laparoscopy does not have prognostic significance for treatment – independent pregnancy at 12 months follow-up. Fertil Steril 2007; 88:s191.##Mol BWJ, Swart P, Bossuyt P, Van der veen F. Is hysterosalpingography an important tool in predicting fertility outcome? Fertil Steril 1997:67; 663-669.##Nordenskjold F, Ahlgren M. Laparoscopy in female infertility. Acta Obstet Gynecol Scand 1983; 62: 609-615.##Farhi J, Ben-Haroush A, Lande Y, Fish B. Role of treatment with ovarian stimulation and intrauterine insemination in women with unilateral tubal occlusion diagnosed by hysterosalpingography. Fertil Steril 2007; 88:396-400.##World Health Organization, Laboratory manual of the examination of human semen and sperm-mucus interaction, Cambridge, University Press, Cambridge, U.K; 1992.##American Fertility Society. Intervention of the infertile couple. Birmingham, AL: American Fertility Society; 1992##Rowe PJ, Comhaire FA, Hargreave TB, Mahmoud AMA. WHO, Manual for the standardized investigation of infertile couples. Cambridge, U K, Cambridge University, Press; 1993.##Chapron C, Querieu D, Bruhat MA, Madelenat P, Frenandez H, Pierre F, Dubuisson JB, Surgical complications of diagnostic and operative gynecological laparoscopy: a series of 29966 cases. Hum Reprod 1998; 13:867-872.##Gutmann JN, Emaging in the evaluation of female infertility. J Reprod Med 1992; 37; 54-61.##Parazzini F, Ablation of lesions or no treatment in minimal-mild endometriosis in infertile women: a randomized trial. Hum Reprod 1999; 14: 1332-1334.##Marcoux S, Maheux R, Berube S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis. N Engl J Med 1997; 337:217-222.##Simon A, Laufer N. Unexplained infertility: a reappraisal. Ass Reprod Rev 1993; 3: 3026-36.##Mol BW, Dijkman B, Wertheim P, Lijmer J, Van der veen F, Bossuy PM, The accuracy of serum Chlamydia antibodies in the diagnosis of tubal pathology: a meta-analysis . Fertil Steril 1997; 67: 1031-1037.##Mol B W, Collins J A, BurrowEA, Van der veen F, Bossoyt P M. Comprison of hysterosalpingography and laparoscopy in predicting fertility outcome. Hum Reprod 1999; 14: 1237-1242.##Dessole S, Battista G, Capobianco G, Menzoni MA, Ambrosini G, Canalis GC. A second hysterosalpingography reduce the use of selective technique for treatment of a proximal tubal obstruction. Fertil Steril 2000; 73: 1037-1039.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>The pregnancy outcome in patients with minor β-thalassemia</TitleF>
		<TitleE>بررسی پیش آگهی حاملگی در بیماران مبتلا به بتا تالاسمی مینور</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: بتا تالاسمی شایع ترین بیماری وراثتی در ایران میباشد و حدود 2 میلیون نفر ناقل ژن بتا تالاسمی در این کشور زندگی می کنند.
هدف : این مطالعه جهت بررسی پیش آگهی حاملگی در بیماران مبتلا به بتا تالاسمی مینور، طراحی شده است.
روش کار : این تحقیق، یک مطالعه مورد-شاهدی است که بر روی بیمارانی که بین سالهای 1385 تا 1388، در 2 بیمارستان دانشگاهی شیراز زایمان داشته اند، انجام شد. بیماران به دو گروه بر اساس حضور بتاتالاسمی مینور تقسیم شدند. بیماران درگروه شاهد و مورد بر اساس سن مادر، سن حاملگی و تعداد حاملگیهای قبلی هماهنگ بودند. انجام سزارین، بیماریهای پرفشاری خون، دیابت حاملگی، پارگی زود رس کیسه آب و زایمان زودرس در هر گروه ثبت و بوسیله تست های &#967;2 &#160;یا &#160;Fisher exact مقایسه گردید. 
نتایج: در کل 510 بیمار بتا تالاسمی مینور و 512 فرد غیر تالاسمی بررسی شده اند. در بیماران با بتا تالاسمی مینور میزان الیگو &#160;هیدرآمینیوس ((p&#60;0.001 و سزارین )p=0.002( ، بالاتر بود. اختلاف معنی دار آماری در آپگار دقیقه یک (p=0.65) ، دقیقه پنج )p=0.25( ، محدودیت رشد داخل رحمی )p=0.74( ، دیابت حاملگی (p=0.43) و پره اکلامپسی (p=0.11) وجود نداشت. 
بحث و نتیجه گیری:&#160; بتا تالاسمی مینور روی پیامد حاملگی تاثیر منفی عمده نداشت.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: &#946;-thalassemia is the most common hereditary disease in Iran and more than 2 million carriers of the &#946;-thalassemia mutant gene are living in this country.
Objective: To determine pregnancy outcome of women with &#946;-thalassemia minor.
Materials and Methods: In this retrospective, case-control study in two universities affiliated hospitals in Shiraz, all pregnancies occurred between 2006 and 2008 were included. Patients were divided in two groups regarding the presence of &#946;-thalassemia minor. Patients in case and control groups were matched according to maternal age, gestational age and number of previous pregnancies. Cesarean delivery, hypertensive disorders, gestational diabetes mellitus, premature rupture of membranes and preterm labor were recorded in each group and were compared using the &#967;2 or Fisher exact tests.&#160;
Results: Overall 510 &#946;-thalassemia minor subjects and 512 healthy controls were studied. Cases with &#946;-thalassemia minor had significantly higher prevalence of oligohydramnios (p&#60;0.001) and cesarean section delivery (p=0.001). There was no significant difference regarding Apgar score in 1st (p=0.65) and 5th minute (p=0.25), IUGR (p=0.073), gestational diabetes mellitus (DM) (p=0.443) and preeclampsia (p=0.116) between two study groups.&#160;&#160;&#160;&#160;
Conclusion: &#946;-thalassemia minor does not significantly influence the pregnancy outcome in the negative way.
&#160;</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>0</FPAGE>
			<TPAGE>0</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2017/10/12017/10/12017/10/12017/10/1
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/7/9
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2017/10/52017/10/52017/10/52017/10/5
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1396/7/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>صدیقه</Name>
				<MidName></MidName>
				<Family>عمویی</Family>
				<NameE>Sedigheh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Amooee</FamilyE>
				<Organizations>
				<Organization>Department of Obstetrics and Gynecology, Shiraz University of Medical Sciences, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>عالمتاج</Name>
				<MidName></MidName>
				<Family>صمصامی</Family>
				<NameE>Alamtaj</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Samsami</FamilyE>
				<Organizations>
				<Organization>Department of Obstetrics and Gynecology, Shiraz University of Medical Sciences, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>جمیله</Name>
				<MidName></MidName>
				<Family>جهانبخش</Family>
				<NameE>Jamileh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Jahanbakhsh</FamilyE>
				<Organizations>
				<Organization>Department of Obstetrics and Gynecology, Shiraz University of Medical Sciences, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>مهران</Name>
				<MidName></MidName>
				<Family>کریمی</Family>
				<NameE>Mehran</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Karimi</FamilyE>
				<Organizations>
				<Organization>Hematology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>karimim@sums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Minor β-thalassemia</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Pregnancy outcome</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Gestational diabetes mellitus</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Oligohydramnios</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>بتا تالاسمی مینور</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>پیامد حاملگی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>دیابت حاملگی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>الیگو هیدرآمینیوس محدودیت رشد داخل رحمی</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Weatherall D, Letsky B. Genetic haematolgical disorders. In: Wald N, ed. Antenatal and Neonatal Screening. 2nd ed. Oxford: Oxford University Press; 1999.##Thein SL. Beta-thalassaemia. Baillieres Clin Haematol 1993; 6: 151–175.##karimi M, Yavarian M, Afrasiabi A, Dehbozorgian J, Rachmilewitz E. Archive Medical Research 2008; 39: 212-214.##Hillman R, Ault K. Hematology in Clinical Practice. 3rd ed. New York: McGraw-Hill; 2002.##Savona-Ventura C, Bonello F. Beta-thalassemia syndromes and pregnancy. Gynecol Surv 1994; 49: 129-137.##Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, et al. Thalassemia in Iran: Epidemiology, Prevention, and Management. J Ped Hematol Oncol 2007; 29: 333-338.##Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F. The beta-thalassemia mutation spectrum in the Iranian population. Hemoglobin 2001; 25: 285–296.##Letsky E. Anemia. In: James D, Steer P, Weiner D, Gonik B, eds. High Risk Pregnancy: Management Options. 2nd ed. London: WB Saunders; 1999: 729-747.##Balgir RS. Infant mortality and reproductive wastage associated with different genotypes of haemoglobinopathies in Orissa, India. Annals of Human Biology 2007; 34: 16-25.##ACOG practice bulletin. Clinical management guidelines for obstetricians-gynecologist. Number 64, July 2005.##Jensen CE, Tuck SM, Wonke B. Fertility in beta thalassaemia major: a report of 16 pregnancies, preconceptual evaluation and a review of the literature. Br J Obstet Gynaecol 1995; 102: 625–629.##Alger LS, Golbus MS, Laros RK Jr. Thalassemia and pregnancy: results of an antenatal screening program. Am J Obstet Gynecol 1979; 134: 662–673.##Skordis N, Christou S, Koliou M, Pavlides N, Angastiniotis M. Fertility in female patients with thalassemia. J Pediatr Endocrinol Metab 1998; 11 (Suppl): 935–943.##Nassar AH, Usta IM, Rechdan JB, Koussa S, Inati A, Taher A. Pregnancy in patients with beta-thalassemia intermedia: outcome of mothers and newborns. Am J Hematol 2006; 81: 499-502.##Savona-Ventura C, Bonello F. Beta-thalassemia syndromes and pregnancy. Obstet Gynecol Surv 1994; 49: 129–137.##Sheiner E, Levy A, Yerushalmi R, Katz M. Beta-Thalassemia Minor During Pregnancy. Obstet Gynecol 2004; 103:1273-1277.##Liaw DC, Kotkiewicz A, Kenker MA. Acute splenic infarct in b thalassemia minor. Hemoglobin 2009; 33: 262-268.##Kanavaki I, Makrythanasis P, Lazaropoulou C, Tsironi M, Kattamis A, Rombos I. Soluble endothelial adhesion molecules and inflammation markers in patients with beta-thalassemia intermedia. Blood cells Mol Dis 2009; 43: 230-234.##Vaeusorn O, Fucharoen S, Wasi P. A study of thalassemia associated with pregnancy. Birth Defects Orig Artic Ser 1988; 23: 295–299.##Weatherall D, Letsky B. Genetic haematolgical disorders. In: Wald N, ed. Antenatal and Neonatal Screening. 2nd ed. Oxford: Oxford University Press; 1999.##Thein SL. Beta-thalassaemia. Baillieres Clin Haematol 1993; 6: 151–175.##karimi M, Yavarian M, Afrasiabi A, Dehbozorgian J, Rachmilewitz E. Archive Medical Research 2008; 39: 212-214.##Hillman R, Ault K. Hematology in Clinical Practice. 3rd ed. New York: McGraw-Hill; 2002.##Savona-Ventura C, Bonello F. Beta-thalassemia syndromes and pregnancy. Gynecol Surv 1994; 49: 129-137.##Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, et al. Thalassemia in Iran: Epidemiology, Prevention, and Management. J Ped Hematol Oncol 2007; 29: 333-338.##Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F. The beta-thalassemia mutation spectrum in the Iranian population. Hemoglobin 2001; 25: 285–296.##Letsky E. Anemia. In: James D, Steer P, Weiner D, Gonik B, eds. High Risk Pregnancy: Management Options. 2nd ed. London: WB Saunders; 1999: 729-747.##Balgir RS. Infant mortality and reproductive wastage associated with different genotypes of haemoglobinopathies in Orissa, India. Annals of Human Biology 2007; 34: 16-25.##ACOG practice bulletin. Clinical management guidelines for obstetricians-gynecologist. Number 64, July 2005.##Jensen CE, Tuck SM, Wonke B. Fertility in beta thalassaemia major: a report of 16 pregnancies, preconceptual evaluation and a review of the literature. Br J Obstet Gynaecol 1995; 102: 625–629.##Alger LS, Golbus MS, Laros RK Jr. Thalassemia and pregnancy: results of an antenatal screening program. Am J Obstet Gynecol 1979; 134: 662–673.##Skordis N, Christou S, Koliou M, Pavlides N, Angastiniotis M. Fertility in female patients with thalassemia. J Pediatr Endocrinol Metab 1998; 11 (Suppl): 935–943.##Nassar AH, Usta IM, Rechdan JB, Koussa S, Inati A, Taher A. Pregnancy in patients with beta-thalassemia intermedia: outcome of mothers and newborns. Am J Hematol 2006; 81: 499-502.##Savona-Ventura C, Bonello F. Beta-thalassemia syndromes and pregnancy. Obstet Gynecol Surv 1994; 49: 129–137.##Sheiner E, Levy A, Yerushalmi R, Katz M. Beta-Thalassemia Minor During Pregnancy. Obstet Gynecol 2004; 103:1273-1277.##Liaw DC, Kotkiewicz A, Kenker MA. Acute splenic infarct in b thalassemia minor. Hemoglobin 2009; 33: 262-268.##Kanavaki I, Makrythanasis P, Lazaropoulou C, Tsironi M, Kattamis A, Rombos I. Soluble endothelial adhesion molecules and inflammation markers in patients with beta-thalassemia intermedia. Blood cells Mol Dis 2009; 43: 230-234.##Vaeusorn O, Fucharoen S, Wasi P. A study of thalassemia associated with pregnancy. Birth Defects Orig Artic Ser 1988; 23: 295–299.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>How does lead induce male infertility?</TitleF>
		<TitleE>چگونه سرب منجر به ناباروری مردان می شود؟</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>قسمت مهمی از ناباروری مردان با علت نامشخص ممکن است در ارتباط با محیط ها و شغلهای مختلفی باشد که باعث تماس با مواد سمی مانند سرب می شوند. اثرات سرب بر روی تولید مثل پیچیده بوده و مسیرهای مختلفی را در بر می گیرد که بسیاری از آنها هنوز کاملاً شناخته نشده اند. بعنوان مثال هنوز مشخص نیست که مشکلات تولید مثل مردان، تحت تاثیر اثر سرب در ارتباط با توزیع هورمونهای جنسی می باشد یا اینکه بر اثر تاثیر مستقیم سرب بر روی غدد جنسی است و یا هر دو؟
پاسخ به این سوال مشکل می باشد زیرا سرب بخصوص با غلظتهای بالا ممکن است اثرات سوئی بر بسیاری از ارگانهای بدن انسان داشته باشد. هرچند که سرب می تواند بوسیله کاهش در تعداد و حرکت اسپرم ها، بوجود آوردن اشکال غیر طبیعی و همچنین تاثیر بر پارامترهای عملکردی باعث ناباروری درمردان گردد، ولی تمام مطالعات قادر به نشان دادن این موضوع نشده اند. بعلاوه مطالعات نشان داده اند &#160;که سد خونی بیضه ها می تواند سلولهای بیضه را در مقابل اثرات مقادیر بالای سرب در خون حفظ نماید. بنا به دلایل ذکر شده و بادر نظر گرفتن اثرات وسیع سرب بر روی هورمونهای تولید مثل، این مطالعه مروری پیشنهاد می کند که اثر اصلی سرب بر روی تولید مثل مردان، احتمالاً بوسیله تغییر دادن محور هورمونهای تولید مثل و کنترل آنها بر روی تولید اسپرم، بجای اثر مستقیم بر روی لوله های اسپرم ساز بیضه عمل می کند. با توجه به آنکه حتی مقادیر کمتر از استاندارد های کاری از غلظت سرب نیز می تواند اثرات سوئی بر روی باروری مردان داشته باشد، لذا مطالعات آینده باید در پی اثبات رابطه بین تماس با سرب ( بخصوص در مقیاس کم) و ناباروری مردان باشند. &#160;مطالعات همچنین باید توجه بیشتری به اثرات سرب بر روی کاهش باروری مردان با توجه به تغییرات محور هورمونی و همچنین تغییرات مشخصات اسپرم داشته باشند.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>An important part of male infertility of unknown etiology may be attributed to various environmental and occupational exposures to toxic substances, such as lead. The reproductive effects of lead are complex and appear to involve multiple pathways, not all of which are fully understood. It is still unclear, for example, if male reproductive issues in lead-exposed persons are mostly related to the disruption of reproductive hormones, whether the problems are due to the lead&#8217;s direct effects on the gonads, or both? This question has been difficult to answer, because lead, especially at high levels, may adversely affect many human organs. Although lead can potentially reduce male fertility by decreasing sperm count and motility, inducing abnormal morphology and affecting functional parameters; not all studies have been able to clearly demonstrate such findings. In addition, research has shown that the blood-testis barrier can protect testicular cells from direct exposure to high levels of blood lead. For these reasons and considering the wide spectrum of lead toxicity on reproductive hormones, the present review suggests that lead&#8217;s main influence on male reproduction probably occurs by altering the reproductive hormonal axis and the hormonal control on spermatogenesis, rather than by a direct toxic effect on the seminiferous tubules of the testes. As blood lead concentrations below the currently accepted worker protection standard may still adversely affect male fertility, future studies should aim to establish more concrete links between lead exposure (especially at low levels) and subsequent male infertility. Research should also pay more attention to lead&#8217;s effects on reducing male fertility rates based on not only hormonal axis alteration, but also on the changes in sperm characteristic among exposed subjects.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>0</FPAGE>
			<TPAGE>0</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2017/10/12017/10/12017/10/12017/10/12017/10/1
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/7/9
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2017/10/52017/10/52017/10/52017/10/52017/10/5
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1396/7/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>محسن</Name>
				<MidName></MidName>
				<Family>ویژه</Family>
				<NameE>Mohsen</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Vigeh</FamilyE>
				<Organizations>
				<Organization>Department of Hazard Evaluation and Epidemiology Research, National Institute of Occupational Safety and Health, Kawasaki, Japan</Organization>
				</Organizations>
				<Countries>
				<Country>ژاپن</Country>
				</Countries>
				<EMAILS>
				<Email>vigeh@h.jniosh.go.jp</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>درک- آر</Name>
				<MidName></MidName>
				<Family>اسمیت</Family>
				<NameE>Smith</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Derek R</FamilyE>
				<Organizations>
				<Organization>School of Health Sciences, Faculty of Health, University of Newcastle, Ourimbah, Australia</Organization>
				</Organizations>
				<Countries>
				<Country>استرالیا</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>پلینگ چی</Name>
				<MidName></MidName>
				<Family>هو</Family>
				<NameE>Ping-Chi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hsu</FamilyE>
				<Organizations>
				<Organization>Departmant of Safety, Health and Environmental Engineering, National Kaohsiung First University of Science and Technology, Kaohsiung, Taiwan</Organization>
				</Organizations>
				<Countries>
				<Country>تایوان</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Lead</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Male reproduction</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Infertility</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Reproductive hormone</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Spermatogenesis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سرب</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تولید مثل مردان</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ناباروری</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>هورمونهای تو لید مثل</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تولید اسپرم.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Tas S, Lauwerys R, Lison D. Occupational hazards for the male reproductive system. Crit Rev Toxicol 1996; 26: 261-307.##Sinclair S. Male infertility: nutritional and environmental considerations. Altern Med Rev 2000; 5: 28-38.##Lahdetie J. Occupation- and exposure-related studies on human sperm. J Occup Environ Med 1995; 37:922-930.##Queiroz EK, Waissmann W: Occupational exposure and effects on the male reproductive system. Cad Saude Publica 2006; 22:485-493.##Apostoli P, Kiss P, Porru S, Bonde JP, Vanhoorne M. Male reproductive toxicity of lead in animals and humans. ASCLEPIOS Study Group. Occup Environ Med 1998; 55:364-374.##Sallmen M, Lindbohm ML, Nurminen M. Paternal exposure to lead and infertility. Epidemiology 2000; 11:148-152.##Chowdhury AR, Rao RV, Gautam AK. Histochemical changes in the testes of lead induced experimental rats. Folia Histochem Cytobiol 1986; 24: 233-237.##Vigeh M, Yokoyama K, Ramezanzadeh F, Dahaghin M, Sakai T, Morita Y, et al. Lead and other trace metals in preeclampsia: a case-control study in Tehran, Iran. Environ Res 2006; 100:268-275.##Sallmen M. Exposure to lead and male fertility. Int J Occup Med Environ Health 2001; 14: 219-222.##Alexander BH, Checkoway H, Faustman EM, van Netten C, Muller CH, Ewers TG. Contrasting associations of blood and semen lead concentrations with semen quality among lead smelter workers. Am J Ind Med 1998; 34: 464-469.##https://doi.org/10.1002/(SICI)1097-0274(199811)34:43.0.CO;2-Z##Pant N, Upadhyay G, Pandey S, Mathur N, Saxena DK, Srivastava SP. Lead and cadmium concentration in the seminal plasma of men in the general population: correlation with sperm quality. Reprod Toxicol 2003; 17:447-450.##Gennart JP, Buchet JP, Roels H, Ghyselen P, Ceulemans E, Lauwerys R. Fertility of male workers exposed to cadmium, lead, or manganese. Am J Epidemiol 1992; 135: 1208-1219.##Lin S, Hwang SA, Marshall EG, Stone R, Chen J. Fertility rates among lead workers and professional bus drivers: a comparative study. Ann Epidemiol 1996; 6: 201-208.##McGivern RF, Sokol RZ, Berman NG. Prenatal lead exposure in the rat during the third week of gestation: long-term behavioral, physiological, and anatomical effects associated with reproduction. Toxicol Appl Pharmacol 1991; 110: 206-215.##Nathan E, Huang HF, Pogach L, Giglio W, Bogden JD, Seebode J. Lead acetate does not impair secretion of Sertoli cell function marker proteins in the adult Sprague Dawley rat. Arch Environ Health 1992; 47:370-375.##Joffe M, Bisanti L, Apostoli P, Kiss P, Dale A, Roeleveld N, et al. Time To Pregnancy and occupational lead exposure. Occup Environ Med 2003; 60:752-758.##Coste J, Mandereau L, Pessione F, Bregu M, Faye C, Hemon D, et al. Lead-exposed workmen and fertility: a cohort study on 354 subjects. Eur J Epidemiol 1991; 7: 154-158.##Bonde JP, Kolstad H. Fertility of Danish battery workers exposed to lead. Int J Epidemiol 1997; 26: 1281-1288.##Shiau CY, Wang JD, Chen PC. Decreased fecundity among male lead workers. Occup Environ Med 2004; 61:915-923.##ATSDR (the Agency for Toxic Substances and Disease Registry): Health Effects. Toxicological Profile for Lead. U.S. Department of Health and Human Services; 2007: 35-151.##Bhasin S, de Kretser DM, Baker HW. Clinical review 64: Pathophysiology and natural history of male infertility. J Clin Endocrinol Metab 1994; 79: 1525-1529.##Oehninger S. Clinical and laboratory management of male infertility: an opinion on its current status. J Androl 2000; 21:814-821.##Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. BMJ 1992; 305: 609-613.##Pasqualotto FF, Locambo CV, Athayde KS, Arap S. Measuring male infertility: epidemiological aspects. Rev Hosp Clin Fac Med Sao Paulo 2003; 58: 173-178.##Telisman S, Cvitkovic P, Jurasovic J, Pizent A, Gavella M, Rocic B. Semen quality and reproductive endocrine function in relation to biomarkers of lead, cadmium, zinc, and copper in men. Environ Health Perspect 2000; 108: 45-53.##Naha N, Bhar RB, Mukherjee A, Chowdhury AR. Structural alteration of spermatozoa in the persons employed in lead acid battery factory. Indian J Physiol Pharmacol 2005; 49: 153-162.##Lancranjan I, Popescu HI, O GA, Klepsch I, Serbanescu M. Reproductive ability of workmen occupationally exposed to lead. Arch Environ Health 1975; 30: 396-401.##Chowdhury AR, Chinoy NJ, Gautam AK, Rao RV, Parikh DJ, Shah GM, et al. Effect of lead on human semen. Adv Contracept Deliv Syst 1986; 2: 208-210.##Cullen MR, Kayne RD, Robins JM. Endocrine and reproductive dysfunction in men associated with occupational inorganic lead intoxication. Arch Environ Health 1984; 39: 431-440.##Telisman S, Colak B, Pizent A, Jurasovic J, Cvitkovic P. Reproductive toxicity of low-level lead exposure in men. Environ Res 2007; 105: 256-266.##Saxena DK, Hussain T, Lal B, Chandra SV. Lead induced testicular dysfunction in weaned rats. Ind Health 1986; 24: 105-109.##Hsu PC, Hsu CC, Liu MY, Chen LY, Guo YL. Lead-induced changes in spermatozoa function and metabolism. J Toxicol Environ Health A 1998; 55:45-64.##Barratt CL, Davies AG, Bansal MR, Williams ME. The effects of lead on the male rat reproductive system. Andrologia 1989; 21: 161-166.##Hsu PC, Liu MY, Hsu CC, Chen LY, Guo YL. Effects of vitamin E and/or C on reactive oxygen species-related lead toxicity in the rat sperm. Toxicology 1998; 128: 169-179.##Wadi SA, Ahmad G. Effects of lead on the male reproductive system in mice. J Toxicol Environ Health A 1999; 56:513-521.##Batra N, Nehru B, Bansal MP. Influence of lead and zinc on rat male reproduction at 'biochemical and histopathological levels'. J Appl Toxicol 2001; 21: 507-512.##Bonde JP, Joffe M, Apostoli P, Dale A, Kiss P, Spano M, et al. Sperm count and chromatin structure in men exposed to inorganic lead: lowest adverse effect levels. Occup Environ Med 2002; 59:234-242.##Willems MI, de Schepper GG, Wibowo AA, Immel HR, Dietrich AJ, Zielhuis RL. Absence of an effect of lead acetate on sperm morphology, sister chromatid exchanges or on micronuclei formation in rabbits. Arch Toxicol 1982; 50: 149-157.##Sokol RZ. The effect of duration of exposure on the expression of lead toxicity on the male reproductive axis. J Androl 1990; 11: 521-526.##Ronis MJ, Badger TM, Shema SJ, Roberson PK, Shaikh F. Reproductive toxicity and growth effects in rats exposed to lead at different periods during development. Toxicol Appl Pharmacol 1996; 136: 361-371.##Saxena DK, Srivastava RS, Lal B, Chandra SV. The effect of lead exposure on the testis of growing rats. Exp Pathol 1987; 31: 249-252.##Adhikari N, Sinha N, Narayan R, Saxena DK. Lead-induced cell death in testes of young rats. J Appl Toxicol 2001; 21: 275-277.##Saxena DK, Lal B, Murthy RC, Chandra SV. Lead induced histochemical changes in the testes of rats. Ind Health 1984; 22: 255-260.##Graca A, Ramalho-Santos J, de Lourdes Pereira M. Effect of lead chloride on spermatogenesis and sperm parameters in mice. Asian J Androl 2004; 6: 237-241.##Eyden BP, Maisin JR, Mattelin G. Long-term effects of dietary lead acetate on survival, body weight and seminal cytology in mice. Bull Environ Contam Toxicol 1978; 19: 266-272.##Foster WG, Singh A, McMahon A, Rice DC. Chronic lead exposure effects in the cynomolgus monkey (Macaca fascicularis) testis. Ultrastruct Pathol 1998; 22: 63-71.##Hernandez-Ochoa I, Garcia-Vargas G, Lopez-Carrillo L, Rubio-Andrade M, Moran-Martinez J, Cebrian ME, et al. Low lead environmental exposure alters semen quality and sperm chromatin condensation in northern Mexico. Reprod Toxicol 2005; 20: 221-228.##Wildt K ER, Berlin M. Effects of occupational exposure to lead on sperm and semen. In: Clarkson TW, Nordberg GF, Sager PR, Reproductive and developmental toxicity of metals. Proceedings of a Joint Meeting, Rochester, NY edition. New York: Plenum Press 1983:279-300.##Viskum S, Rabjerg L, Jorgensen PJ, Grandjean P. Improvement in semen quality associated with decreasing occupational lead exposure. Am J Ind Med 1999; 35: 257-263.##https://doi.org/10.1002/(SICI)1097-0274(199903)35:33.0.CO;2-###Mortensen JT. Risk for reduced sperm quality among metal workers, with special reference to welders. Scand J Work Environ Health 1988; 14: 27-30.##Xuezhi J, Youxin L, Yilan W. Studies of lead exposure on reproductive system: a review of work in China. Biomed Environ Sci 1992; 5: 266-275.##Benoff S, Centola GM, Millan C, Napolitano B, Marmar JL, Hurley IR. Increased seminal plasma lead levels adversely affect the fertility potential of sperm in IVF. Hum Reprod 2003; 18: 374-383.##Benoff S, Hurley IR, Millan C, Napolitano B, Centola GM. Seminal lead concentrations negatively affect outcomes of artificial insemination. Fertil Steril 2003; 80: 517-525.##Chowdhuri DK, Narayan R, Saxena DK. Effect of lead and chromium on nucleic acid and protein synthesis during sperm-zona binding in mice. Toxicol In Vitro 2001; 15: 605-613.##Johansson L. Premature acrosome reaction in spermatozoa from lead-exposed mice. Toxicology 1989; 54: 151-162.##Al-Hakkak ZS, Zahid ZR, Ibrahim DK, al-Jumaily IS, Bazzaz AA. Effects of ingestion of lead monoxide alloy on male mouse reproduction. Arch Toxicol 1988; 62: 97-100.##Sokol RZ, Madding CE, Swerdloff RS. Lead toxicity and the hypothalamic-pituitary-testicular axis. Biol Reprod 1985; 33: 722-728.##Sokol RZ, Wang S, Wan YJ, Stanczyk FZ, Gentzschein E, Chapin RE. Long-term, low-dose lead exposure alters the gonadotropin-releasing hormone system in the male rat. Environ Health Perspect 2002; 110: 871-874.##Sokol RZ. Hormonal effects of lead acetate in the male rat: mechanism of action. Biol Reprod 1987; 37: 1135-1138.##McGregor AJ, Mason HJ. Chronic occupational lead exposure and testicular endocrine function. Hum Exp Toxicol 1990; 9: 371-376.##Ng TP, Goh HH, Ng YL, Ong HY, Ong CN, Chia KS, et al. Male endocrine functions in workers with moderate exposure to lead. Br J Ind Med 1991; 48: 485-491.##Rodamilans M, Osaba MJ, To-Figueras J, Rivera Fillat F, Marques JM, Perez P, et al. Lead toxicity on endocrine testicular function in an occupationally exposed population. Hum Toxicol 1988; 7: 125-128.##Gustafson A, Hedner P, Schutz A, Skerfving S. Occupational lead exposure and pituitary function. Int Arch Occup Environ Health 1989; 61: 277-281.##Wiebe JP, Salhanick AI, Myers KI. On the mechanism of action of lead in the testis: in vitro suppression of FSH receptors, cyclic AMP and steroidogenesis. Life Sci 1983; 32:1997-2005.##Grattan DR, Rocca MS, Sagrillo CA, McCarthy MM, Selmanoff M. Antiandrogen microimplants into the rostral medial preoptic area decrease gamma-aminobutyric acidergic neuronal activity and increase luteinizing hormone secretion in the intact male rat. Endocrinology 1996; 137: 4167-4173.##Petrusz P, Weaver CM, Grant LD, Mushak P, Krigman MR. Lead poisoning and reproduction: effects on pituitary and serum gonadotropins in neonatal rats. Environ Res 1979; 19: 383-391.##Assennato G, Paci C, Baser ME, Molinini R, Candela RG, Altamura BM, et al. Sperm count suppression without endocrine dysfunction in lead-exposed men. Arch Environ Health 1987; 42:124-127.##Pinon-Lataillade G, Thoreux-Manlay A, Coffigny H, Masse R, Soufir JC. Reproductive toxicity of chronic lead exposure in male and female mice. Hum Exp Toxicol 1995; 14:872-878.##Mahmoud A, Kiss P, Vanhoorne M, De Bacquer D, Comhaire F. Is inhibin B involved in the toxic effect of lead on male reproduction? International journal of andrology 2005; 28: 150-155.##Foster WG, McMahon A, YoungLai EV, Hughes EG, Rice DC. Reproductive endocrine effects of chronic lead exposure in the male cynomolgus monkey. Reprod Toxicol 1993; 7: 203-209.##Boscolo P, Carmignani M, Sacchettoni-Logroscino G, Rannelletti FO, Artese L, Preziosi P. Ultrastructure of the testis in rats with blood hypertension induced by long-term lead exposure. Toxicol Lett 1988; 41: 129-137.##Benoff S, Jacob A, Hurley IR: Male infertility and environmental exposure to lead and cadmium. Hum Reprod Update 2000; 6:107-121.##Saxena DK, Murthy RC, Lal B, Chandra SV. Lead induced testicular changes in protein malnourished rats. Folia Histochem Cytobiol 1989; 27: 57-61.##Vaziri ND, Khan M. Interplay of reactive oxygen species and nitric oxide in the pathogenesis of experimental lead-induced hypertension. Clin Exp Pharmacol Physiol 2007; 34:920-925.##Ni Z, Hou S, Barton CH, Vaziri ND. Lead exposure raises superoxide and hydrogen peroxide in human endothelial and vascular smooth muscle cells. Kidney Int 2004; 66: 2329-2336.##Patrick L. Lead toxicity part II: the role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity. Altern Med Rev 2006; 11: 114-127.##Kiziler AR, Aydemir B, Onaran I, Alici B, Ozkara H, Gulyasar T, et al. High levels of cadmium and lead in seminal fluid and blood of smoking men are associated with high oxidative stress and damage in infertile subjects. Biol Trace Elem Res 2007; 120: 82-91.##Kasperczyk S, Birkner E, Kasperczyk A, Zalejska-Fiolka J. Activity of superoxide dismutase and catalase in people protractedly exposed to lead compounds. Ann Agric Environ Med 2004; 11: 291-296.##Hsu PC, Hsu CC, Guo YL. Hydrogen peroxide induces premature acrosome reaction in rat sperm and reduces their penetration of the zona pellucida. Toxicology 1999; 139: 93-101.##Hsu PC, Guo YL. Antioxidant nutrients and lead toxicity. Toxicology 2002; 180: 33-44.##Hsu PC, Liu MY, Hsu CC, Chen LY, Leon Guo Y: Lead exposure causes generation of reactive oxygen species and functional impairment in rat sperm. Toxicology 1997; 122: 133-143.##Marchlewicz M, Wiszniewska B, Gonet B, Baranowska-Bosiacka I, Safranow K, Kolasa A, et al. Increased lipid peroxidation and ascorbic Acid utilization in testis and epididymis of rats chronically exposed to lead. Biometals 2007; 20: 13-19.##Teijon C, Olmo R, Blanco D, Romero A, Teijon JM. Low doses of lead: effects on reproduction and development in rats. Biol Trace Elem Res 2006; 111:151-165.##Apostoli P, Bellini A, Porru S, Bisanti L. The effect of lead on male fertility: a time to pregnancy (TTP) study. American journal of industrial medicine 2000; 38: 310-315.##https://doi.org/10.1002/1097-0274(200009)38:33.0.CO;2-9##El-Zohairy EA, Youssef AF, Abul-Nasr SM, Fahmy IM, Salem D, Kahil AK, et al. Reproductive hazards of lead exposure among urban Egyptian men. Reprod Toxicol 1996; 10:145-151.##Xu B, Chia SE, Tsakok M, Ong CN. Trace elements in blood and seminal plasma and their relationship to sperm quality. Reprod Toxicol 1993; 7: 613-618.##Alexander BH, Checkoway H, van Netten C, Muller CH, Ewers TG, Kaufman JD, et al. Semen quality of men employed at a lead smelter. Occup Environ Med 1996; 53:411-416.##Tas S, Lauwerys R, Lison D. Occupational hazards for the male reproductive system. Crit Rev Toxicol 1996; 26: 261-307.##Sinclair S. Male infertility: nutritional and environmental considerations. Altern Med Rev 2000; 5: 28-38.##Lahdetie J. Occupation- and exposure-related studies on human sperm. J Occup Environ Med 1995; 37:922-930.##Queiroz EK, Waissmann W: Occupational exposure and effects on the male reproductive system. Cad Saude Publica 2006; 22:485-493.##Apostoli P, Kiss P, Porru S, Bonde JP, Vanhoorne M. Male reproductive toxicity of lead in animals and humans. ASCLEPIOS Study Group. Occup Environ Med 1998; 55:364-374.##Sallmen M, Lindbohm ML, Nurminen M. Paternal exposure to lead and infertility. Epidemiology 2000; 11:148-152.##Chowdhury AR, Rao RV, Gautam AK. Histochemical changes in the testes of lead induced experimental rats. Folia Histochem Cytobiol 1986; 24: 233-237.##Vigeh M, Yokoyama K, Ramezanzadeh F, Dahaghin M, Sakai T, Morita Y, et al. Lead and other trace metals in preeclampsia: a case-control study in Tehran, Iran. Environ Res 2006; 100:268-275.##Sallmen M. Exposure to lead and male fertility. Int J Occup Med Environ Health 2001; 14: 219-222.##Alexander BH, Checkoway H, Faustman EM, van Netten C, Muller CH, Ewers TG. Contrasting associations of blood and semen lead concentrations with semen quality among lead smelter workers. Am J Ind Med 1998; 34: 464-469.##https://doi.org/10.1002/(SICI)1097-0274(199811)34:43.0.CO;2-Z##Pant N, Upadhyay G, Pandey S, Mathur N, Saxena DK, Srivastava SP. Lead and cadmium concentration in the seminal plasma of men in the general population: correlation with sperm quality. Reprod Toxicol 2003; 17:447-450.##Gennart JP, Buchet JP, Roels H, Ghyselen P, Ceulemans E, Lauwerys R. Fertility of male workers exposed to cadmium, lead, or manganese. Am J Epidemiol 1992; 135: 1208-1219.##Lin S, Hwang SA, Marshall EG, Stone R, Chen J. Fertility rates among lead workers and professional bus drivers: a comparative study. Ann Epidemiol 1996; 6: 201-208.##McGivern RF, Sokol RZ, Berman NG. Prenatal lead exposure in the rat during the third week of gestation: long-term behavioral, physiological, and anatomical effects associated with reproduction. Toxicol Appl Pharmacol 1991; 110: 206-215.##Nathan E, Huang HF, Pogach L, Giglio W, Bogden JD, Seebode J. Lead acetate does not impair secretion of Sertoli cell function marker proteins in the adult Sprague Dawley rat. Arch Environ Health 1992; 47:370-375.##Joffe M, Bisanti L, Apostoli P, Kiss P, Dale A, Roeleveld N, et al. Time To Pregnancy and occupational lead exposure. Occup Environ Med 2003; 60:752-758.##Coste J, Mandereau L, Pessione F, Bregu M, Faye C, Hemon D, et al. Lead-exposed workmen and fertility: a cohort study on 354 subjects. Eur J Epidemiol 1991; 7: 154-158.##Bonde JP, Kolstad H. Fertility of Danish battery workers exposed to lead. Int J Epidemiol 1997; 26: 1281-1288.##Shiau CY, Wang JD, Chen PC. Decreased fecundity among male lead workers. Occup Environ Med 2004; 61:915-923.##ATSDR (the Agency for Toxic Substances and Disease Registry): Health Effects. Toxicological Profile for Lead. U.S. Department of Health and Human Services; 2007: 35-151.##Bhasin S, de Kretser DM, Baker HW. Clinical review 64: Pathophysiology and natural history of male infertility. J Clin Endocrinol Metab 1994; 79: 1525-1529.##Oehninger S. Clinical and laboratory management of male infertility: an opinion on its current status. J Androl 2000; 21:814-821.##Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. BMJ 1992; 305: 609-613.##Pasqualotto FF, Locambo CV, Athayde KS, Arap S. Measuring male infertility: epidemiological aspects. Rev Hosp Clin Fac Med Sao Paulo 2003; 58: 173-178.##Telisman S, Cvitkovic P, Jurasovic J, Pizent A, Gavella M, Rocic B. Semen quality and reproductive endocrine function in relation to biomarkers of lead, cadmium, zinc, and copper in men. Environ Health Perspect 2000; 108: 45-53.##Naha N, Bhar RB, Mukherjee A, Chowdhury AR. Structural alteration of spermatozoa in the persons employed in lead acid battery factory. Indian J Physiol Pharmacol 2005; 49: 153-162.##Lancranjan I, Popescu HI, O GA, Klepsch I, Serbanescu M. Reproductive ability of workmen occupationally exposed to lead. Arch Environ Health 1975; 30: 396-401.##Chowdhury AR, Chinoy NJ, Gautam AK, Rao RV, Parikh DJ, Shah GM, et al. Effect of lead on human semen. Adv Contracept Deliv Syst 1986; 2: 208-210.##Cullen MR, Kayne RD, Robins JM. Endocrine and reproductive dysfunction in men associated with occupational inorganic lead intoxication. Arch Environ Health 1984; 39: 431-440.##Telisman S, Colak B, Pizent A, Jurasovic J, Cvitkovic P. Reproductive toxicity of low-level lead exposure in men. Environ Res 2007; 105: 256-266.##Saxena DK, Hussain T, Lal B, Chandra SV. Lead induced testicular dysfunction in weaned rats. Ind Health 1986; 24: 105-109.##Hsu PC, Hsu CC, Liu MY, Chen LY, Guo YL. Lead-induced changes in spermatozoa function and metabolism. J Toxicol Environ Health A 1998; 55:45-64.##Barratt CL, Davies AG, Bansal MR, Williams ME. The effects of lead on the male rat reproductive system. Andrologia 1989; 21: 161-166.##Hsu PC, Liu MY, Hsu CC, Chen LY, Guo YL. Effects of vitamin E and/or C on reactive oxygen species-related lead toxicity in the rat sperm. Toxicology 1998; 128: 169-179.##Wadi SA, Ahmad G. Effects of lead on the male reproductive system in mice. J Toxicol Environ Health A 1999; 56:513-521.##Batra N, Nehru B, Bansal MP. Influence of lead and zinc on rat male reproduction at 'biochemical and histopathological levels'. J Appl Toxicol 2001; 21: 507-512.##Bonde JP, Joffe M, Apostoli P, Dale A, Kiss P, Spano M, et al. Sperm count and chromatin structure in men exposed to inorganic lead: lowest adverse effect levels. Occup Environ Med 2002; 59:234-242.##Willems MI, de Schepper GG, Wibowo AA, Immel HR, Dietrich AJ, Zielhuis RL. Absence of an effect of lead acetate on sperm morphology, sister chromatid exchanges or on micronuclei formation in rabbits. Arch Toxicol 1982; 50: 149-157.##Sokol RZ. The effect of duration of exposure on the expression of lead toxicity on the male reproductive axis. J Androl 1990; 11: 521-526.##Ronis MJ, Badger TM, Shema SJ, Roberson PK, Shaikh F. Reproductive toxicity and growth effects in rats exposed to lead at different periods during development. Toxicol Appl Pharmacol 1996; 136: 361-371.##Saxena DK, Srivastava RS, Lal B, Chandra SV. The effect of lead exposure on the testis of growing rats. Exp Pathol 1987; 31: 249-252.##Adhikari N, Sinha N, Narayan R, Saxena DK. Lead-induced cell death in testes of young rats. J Appl Toxicol 2001; 21: 275-277.##Saxena DK, Lal B, Murthy RC, Chandra SV. Lead induced histochemical changes in the testes of rats. Ind Health 1984; 22: 255-260.##Graca A, Ramalho-Santos J, de Lourdes Pereira M. Effect of lead chloride on spermatogenesis and sperm parameters in mice. Asian J Androl 2004; 6: 237-241.##Eyden BP, Maisin JR, Mattelin G. Long-term effects of dietary lead acetate on survival, body weight and seminal cytology in mice. Bull Environ Contam Toxicol 1978; 19: 266-272.##Foster WG, Singh A, McMahon A, Rice DC. Chronic lead exposure effects in the cynomolgus monkey (Macaca fascicularis) testis. Ultrastruct Pathol 1998; 22: 63-71.##Hernandez-Ochoa I, Garcia-Vargas G, Lopez-Carrillo L, Rubio-Andrade M, Moran-Martinez J, Cebrian ME, et al. Low lead environmental exposure alters semen quality and sperm chromatin condensation in northern Mexico. Reprod Toxicol 2005; 20: 221-228.##Wildt K ER, Berlin M. Effects of occupational exposure to lead on sperm and semen. In: Clarkson TW, Nordberg GF, Sager PR, Reproductive and developmental toxicity of metals. Proceedings of a Joint Meeting, Rochester, NY edition. New York: Plenum Press 1983:279-300.##Viskum S, Rabjerg L, Jorgensen PJ, Grandjean P. Improvement in semen quality associated with decreasing occupational lead exposure. Am J Ind Med 1999; 35: 257-263.##https://doi.org/10.1002/(SICI)1097-0274(199903)35:33.0.CO;2-###Mortensen JT. Risk for reduced sperm quality among metal workers, with special reference to welders. Scand J Work Environ Health 1988; 14: 27-30.##Xuezhi J, Youxin L, Yilan W. Studies of lead exposure on reproductive system: a review of work in China. Biomed Environ Sci 1992; 5: 266-275.##Benoff S, Centola GM, Millan C, Napolitano B, Marmar JL, Hurley IR. Increased seminal plasma lead levels adversely affect the fertility potential of sperm in IVF. Hum Reprod 2003; 18: 374-383.##Benoff S, Hurley IR, Millan C, Napolitano B, Centola GM. Seminal lead concentrations negatively affect outcomes of artificial insemination. Fertil Steril 2003; 80: 517-525.##Chowdhuri DK, Narayan R, Saxena DK. Effect of lead and chromium on nucleic acid and protein synthesis during sperm-zona binding in mice. Toxicol In Vitro 2001; 15: 605-613.##Johansson L. Premature acrosome reaction in spermatozoa from lead-exposed mice. Toxicology 1989; 54: 151-162.##Al-Hakkak ZS, Zahid ZR, Ibrahim DK, al-Jumaily IS, Bazzaz AA. Effects of ingestion of lead monoxide alloy on male mouse reproduction. Arch Toxicol 1988; 62: 97-100.##Sokol RZ, Madding CE, Swerdloff RS. Lead toxicity and the hypothalamic-pituitary-testicular axis. Biol Reprod 1985; 33: 722-728.##Sokol RZ, Wang S, Wan YJ, Stanczyk FZ, Gentzschein E, Chapin RE. Long-term, low-dose lead exposure alters the gonadotropin-releasing hormone system in the male rat. Environ Health Perspect 2002; 110: 871-874.##Sokol RZ. Hormonal effects of lead acetate in the male rat: mechanism of action. Biol Reprod 1987; 37: 1135-1138.##McGregor AJ, Mason HJ. Chronic occupational lead exposure and testicular endocrine function. Hum Exp Toxicol 1990; 9: 371-376.##Ng TP, Goh HH, Ng YL, Ong HY, Ong CN, Chia KS, et al. Male endocrine functions in workers with moderate exposure to lead. Br J Ind Med 1991; 48: 485-491.##Rodamilans M, Osaba MJ, To-Figueras J, Rivera Fillat F, Marques JM, Perez P, et al. Lead toxicity on endocrine testicular function in an occupationally exposed population. Hum Toxicol 1988; 7: 125-128.##Gustafson A, Hedner P, Schutz A, Skerfving S. Occupational lead exposure and pituitary function. Int Arch Occup Environ Health 1989; 61: 277-281.##Wiebe JP, Salhanick AI, Myers KI. On the mechanism of action of lead in the testis: in vitro suppression of FSH receptors, cyclic AMP and steroidogenesis. Life Sci 1983; 32:1997-2005.##Grattan DR, Rocca MS, Sagrillo CA, McCarthy MM, Selmanoff M. Antiandrogen microimplants into the rostral medial preoptic area decrease gamma-aminobutyric acidergic neuronal activity and increase luteinizing hormone secretion in the intact male rat. Endocrinology 1996; 137: 4167-4173.##Petrusz P, Weaver CM, Grant LD, Mushak P, Krigman MR. Lead poisoning and reproduction: effects on pituitary and serum gonadotropins in neonatal rats. Environ Res 1979; 19: 383-391.##Assennato G, Paci C, Baser ME, Molinini R, Candela RG, Altamura BM, et al. Sperm count suppression without endocrine dysfunction in lead-exposed men. Arch Environ Health 1987; 42:124-127.##Pinon-Lataillade G, Thoreux-Manlay A, Coffigny H, Masse R, Soufir JC. Reproductive toxicity of chronic lead exposure in male and female mice. Hum Exp Toxicol 1995; 14:872-878.##Mahmoud A, Kiss P, Vanhoorne M, De Bacquer D, Comhaire F. Is inhibin B involved in the toxic effect of lead on male reproduction? International journal of andrology 2005; 28: 150-155.##Foster WG, McMahon A, YoungLai EV, Hughes EG, Rice DC. Reproductive endocrine effects of chronic lead exposure in the male cynomolgus monkey. Reprod Toxicol 1993; 7: 203-209.##Boscolo P, Carmignani M, Sacchettoni-Logroscino G, Rannelletti FO, Artese L, Preziosi P. Ultrastructure of the testis in rats with blood hypertension induced by long-term lead exposure. Toxicol Lett 1988; 41: 129-137.##Benoff S, Jacob A, Hurley IR: Male infertility and environmental exposure to lead and cadmium. Hum Reprod Update 2000; 6:107-121.##Saxena DK, Murthy RC, Lal B, Chandra SV. Lead induced testicular changes in protein malnourished rats. Folia Histochem Cytobiol 1989; 27: 57-61.##Vaziri ND, Khan M. Interplay of reactive oxygen species and nitric oxide in the pathogenesis of experimental lead-induced hypertension. Clin Exp Pharmacol Physiol 2007; 34:920-925.##Ni Z, Hou S, Barton CH, Vaziri ND. Lead exposure raises superoxide and hydrogen peroxide in human endothelial and vascular smooth muscle cells. Kidney Int 2004; 66: 2329-2336.##Patrick L. Lead toxicity part II: the role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity. Altern Med Rev 2006; 11: 114-127.##Kiziler AR, Aydemir B, Onaran I, Alici B, Ozkara H, Gulyasar T, et al. High levels of cadmium and lead in seminal fluid and blood of smoking men are associated with high oxidative stress and damage in infertile subjects. Biol Trace Elem Res 2007; 120: 82-91.##Kasperczyk S, Birkner E, Kasperczyk A, Zalejska-Fiolka J. Activity of superoxide dismutase and catalase in people protractedly exposed to lead compounds. Ann Agric Environ Med 2004; 11: 291-296.##Hsu PC, Hsu CC, Guo YL. Hydrogen peroxide induces premature acrosome reaction in rat sperm and reduces their penetration of the zona pellucida. Toxicology 1999; 139: 93-101.##Hsu PC, Guo YL. Antioxidant nutrients and lead toxicity. Toxicology 2002; 180: 33-44.##Hsu PC, Liu MY, Hsu CC, Chen LY, Leon Guo Y: Lead exposure causes generation of reactive oxygen species and functional impairment in rat sperm. Toxicology 1997; 122: 133-143.##Marchlewicz M, Wiszniewska B, Gonet B, Baranowska-Bosiacka I, Safranow K, Kolasa A, et al. Increased lipid peroxidation and ascorbic Acid utilization in testis and epididymis of rats chronically exposed to lead. Biometals 2007; 20: 13-19.##Teijon C, Olmo R, Blanco D, Romero A, Teijon JM. Low doses of lead: effects on reproduction and development in rats. Biol Trace Elem Res 2006; 111:151-165.##Apostoli P, Bellini A, Porru S, Bisanti L. The effect of lead on male fertility: a time to pregnancy (TTP) study. American journal of industrial medicine 2000; 38: 310-315.##https://doi.org/10.1002/1097-0274(200009)38:33.0.CO;2-9##El-Zohairy EA, Youssef AF, Abul-Nasr SM, Fahmy IM, Salem D, Kahil AK, et al. Reproductive hazards of lead exposure among urban Egyptian men. Reprod Toxicol 1996; 10:145-151.##Xu B, Chia SE, Tsakok M, Ong CN. Trace elements in blood and seminal plasma and their relationship to sperm quality. Reprod Toxicol 1993; 7: 613-618.##Alexander BH, Checkoway H, van Netten C, Muller CH, Ewers TG, Kaufman JD, et al. Semen quality of men employed at a lead smelter. Occup Environ Med 1996; 53:411-416.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>The correlation of factors affecting the endometrial thickness with pregnancy outcome in the IUI cycles</TitleF>
		<TitleE>ارتباط فاکتورهای موثر بر ضخامت آندومتر با بروز حاملگی در سیکل های IUI</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: مطالعات زیادی برای درک اثر ضخامت آندومتر بر روی پیش آگهی باروری انجام شده است، در حالیکه فاکتورهای موثر بر روی ضخامت آندومتر هنوز ناشناخته اند.
هدف: این مطالعه، برای تعیین فاکتورهایی نظیر سن و تعداد فولیکول ها که میتوانند ضخامت آندومتر را تحت تاثیر قرار دهند، انجام شده است.
مواد و روش ها: این مطالعه به صورت گذشته نگر بر روی 680 زن نابارور که کاندید IUI &#160;&#160;بودند، انجام شد. پروتکل دارویی IUI &#160;شامل: رژیم کلومید و گنادوتروپین بود و ضخامت آندومتر در روز تزریق HCG تعیین شد. ارتباط بین ضخامت آندومتر و مواردی چون سن، تعداد کل فولیکول ها ، اندازه فولیکول ها ، تعداد آمپولهای گنادوتروپین و میزان حاملگی مورد سنجش قرار گرفت.
نتایج: میانگین ضخامت آندومتر8/1&#160;2/7 میلیمتر بود. آندومتر در بیماران مسن تر نازک تر در مقایسه با جوان تر ها بود، اما در همه گروههای سنی میزان حاملگی در ضخامت آندومتر بیشتر از 6 و کمتر یا مساوی 10 میلی متر بالاتر بود. ( 0.05 &#60; p) 
نتیجه گیری: ما ارتباط معنی دار &#160;آماری بین سن ، تعداد فولیکول ها و تعداد آمپول های گنادوتروپین با ضخامت آندومتر پیدا نکردیم، اما در تمام گروهها ی سنی شانس حاملگی با ضخامت آندومتر بیشتر&#160; از 6 و کمتر یا مساوی 10 میلی متر، بالاتر بود.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Many studies have been carried out to understand the effect of endometrial thickness on the reproductive outcome while the factors affecting the pattern itself are still unknown.
Objective: To determine the factors such as age and the number of follicles that could affect the endometrial thickness
Materials and Methods: This study was conducted as a retrospective study on 680 infertile women considered for intrauterine insemination (IUI). IUI protocol was sequential regimen of clomid and gonadotropin. Endometrial thickness measurement was done on the day of HCG administration. Correlation between endometrial thickness and factors such as age, total follicle numbers, dominant follicle numbers, gonadotropine ampule numbers and pregnancy rate were assessed.
Results:&#160;The mean endometrial thickness was 7.2&#177;1.8 mm. The endometrium was thinner in older patients compared with younger ones. But in all age ranges pregnancy rate was higher in endometrial thickness 6&#60; ET&#8804;10 mm (p&#60;0.05).
Conclusion: We did not find any correlation between age,&#160; number of follicles and gonadotropine ampoules with endometrial thickness but in all age ranges, there is a possibility of higher chance of pregnancy in endometrial thickness 6 &#60; ET&#8804;10 mm.&#160;</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>0</FPAGE>
			<TPAGE>0</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2017/10/12017/10/12017/10/12017/10/12017/10/12017/10/1
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/7/9
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2017/10/52017/10/52017/10/52017/10/52017/10/52017/10/5
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1396/7/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>ویکتوریا</Name>
				<MidName></MidName>
				<Family>حبیب زاده</Family>
				<NameE>Victoria</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Habibzadeh</FamilyE>
				<Organizations>
				<Organization>Afzalipour Clinical Center for Infertility, Kerman University of Medical Sciences, Afzalipour Hospital, Kerman, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>V.habibzadeh@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>سید نورالدین</Name>
				<MidName></MidName>
				<Family>نعمت اللهی ماهانی</Family>
				<NameE>Sayed Noureddin</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Nematolahi Mahani</FamilyE>
				<Organizations>
				<Organization>Department of Anatomy and Embryology, Faculty of Medicine, Kerman University of Medical Sciences</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>حدیث</Name>
				<MidName></MidName>
				<Family>کامیاب</Family>
				<NameE>Hadiss</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Kamyab</FamilyE>
				<Organizations>
				<Organization>Afzalipour Clinical Center for Infertility, Kerman University of Medical Sciences, Afzalipour Hospital, Kerman, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Endometrial thickness</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Affecting factors</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Intrauterine insemination</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Pregnancy rate</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ضخامت آندومتر</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>فاکتورهای موثر</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تلقیح داخل رحمی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>میزان حاملگی</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Dieterich C. Increased endometrial thickness on the day of HCC, injection does not adversely affect pregnancy. Fertil Steril 2002, 77: 781.##Noci I- Aging of the human endometrium. European obstetric. Gynecology reproductive biology 1995: 66:181.##Lamanna G. Sciosscia m. Lorusso F-serrate E. selvagi IE. The pregnancy rate increased as the endometrial thickness. Fertility Sterility. 2007 – www.obGyn.net .##Zahir Z.sharani S.H. Roshan Z.there was no statistically significant difference in pregnancy rate in three groups of endometrial thickness (14). IRMS 2007; 12: 257-261.##Al-inary Ahmed M.Abous. setta there was no significant difference in pregnancy rate between all groups in relation to both endometrial thickness. Middle East Fertility Society Journal 2005; 63-67.##De Geyter C , Schmitter M , De Gayter M , Niesch lagE , Holzgreve W , Shnieder HP. Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 10186 infertile women. Fertile Steril 2000; 73:106##Martin W, D – Ferriani KA – mastri co-Maria R-Filho FM.The endometrial volume increase was higher in pregnant women than in non pregnant women. Fertil Steril 2007 –www.obGyn.net##Doneness j.What of the imprication of myoma. Fertility. Sterility Hum Reprod 2002:14:24.##Nabil–EI Tabbakh. Endometrial advancement has been described after HMG stimulation. www.ObGyn.net##Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterin leiomyoma in black and white women. Ultra sound evidence. Am j obstet Gynecol 2003:188:100##Donnez j. jadoul p. What are the implications of myomas on fertility? A need for a debate? Hum Reprod 2002:17:1424-1430##Weissman A-Gotlieb L. Casper RF. The detrimental effect of increased endometrial thickness on implantation and pregnancy rates. Fertil Steril 1999: 71: 147-149.##Gentry WL. Use of endometrial measurement as an exclusion criterion for in vitro fertilization using clomiphen citrate. J Reproductive Med 1996 41: 545-547.##Reuter H,Cohen.S, Fureg C.Baker.S, sonographic appearance of the endometrium and ovaries during cycles stimulated with human menopausal gouadotropin. J Reprod Med 1996: 41: 509- 514.##Tomlinson Mj.prognostic indicators for intrauterine insemination (IUI): statistical model for IUI success. Human Reprod 1996; 11:1892-1896.##Hock DL Sonographic assessment of endometrial pattern and thickness in patients treated with CC, HMG and IUI. Fertil Steril 1997; 68: 242-245.##Tsai HD, Change CC, Hsieh YY, Lee CC. lolly. Artificial insemination. Role of ET and patiern, of vascular impedence of the spiral and uterine arteries, and of the dominant follicle. J Reprod Med 2000; 45: 195-200.##Hsieh YY. Low dose aspirin for infertile women with thin endometrium receiving intrauterine insemination: a perspective randomized Study. J Assist Reprod Genet 2000 17: 174-177.##Zollner U. Impact of 3-D measured endometrial volume on the pregnancy rate after IUI. Zentralbi Gynakol 2003; 125: 136-141.##Kolibiianahis E.M.Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for IUI. Reprod Biomed online 2004; 8: 115-118.##Unfer V. High does of phytoestrognes can reverse the antiestrogenic effect of cc on the endometrium in patients undergoing IUI: A randomized trial. J Soc Gynecol Interesting 2004; 11: 323-328##Esmailzadeh, S, Endometrial thickness and pregnancy outcome after IUI. Fertility Sterility 2007 88: 432 – 437.##Merviel. P. Predictive factors for pregnancy after IUI: An analysis of 1038 cycles and a review of the literature. Fertil Steril 2008. Nov 7.##Dickey Rp, olar TT, Taylor SN, Curok DN, Matulich EM. Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: ffect of cc alone and with HMG. Fertil Steril 1993; 59: 756-760.##Wiser Amir M.D .Baum Micha M.D predicting factors for ET during treatment with ART. Fertil Steril 2007; 87: 799-804.##Dieterich C. Increased endometrial thickness on the day of HCC, injection does not adversely affect pregnancy. Fertil Steril 2002, 77: 781.##Noci I- Aging of the human endometrium. European obstetric. Gynecology reproductive biology 1995: 66:181.##Lamanna G. Sciosscia m. Lorusso F-serrate E. selvagi IE. The pregnancy rate increased as the endometrial thickness. Fertility Sterility. 2007 – www.obGyn.net .##Zahir Z.sharani S.H. Roshan Z.there was no statistically significant difference in pregnancy rate in three groups of endometrial thickness (14). IRMS 2007; 12: 257-261.##Al-inary Ahmed M.Abous. setta there was no significant difference in pregnancy rate between all groups in relation to both endometrial thickness. Middle East Fertility Society Journal 2005; 63-67.##De Geyter C , Schmitter M , De Gayter M , Niesch lagE , Holzgreve W , Shnieder HP. Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 10186 infertile women. Fertile Steril 2000; 73:106##Martin W, D – Ferriani KA – mastri co-Maria R-Filho FM.The endometrial volume increase was higher in pregnant women than in non pregnant women. Fertil Steril 2007 –www.obGyn.net##Doneness j.What of the imprication of myoma. Fertility. Sterility Hum Reprod 2002:14:24.##Nabil–EI Tabbakh. Endometrial advancement has been described after HMG stimulation. www.ObGyn.net##Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterin leiomyoma in black and white women. Ultra sound evidence. Am j obstet Gynecol 2003:188:100##Donnez j. jadoul p. What are the implications of myomas on fertility? A need for a debate? Hum Reprod 2002:17:1424-1430##Weissman A-Gotlieb L. Casper RF. The detrimental effect of increased endometrial thickness on implantation and pregnancy rates. Fertil Steril 1999: 71: 147-149.##Gentry WL. Use of endometrial measurement as an exclusion criterion for in vitro fertilization using clomiphen citrate. J Reproductive Med 1996 41: 545-547.##Reuter H,Cohen.S, Fureg C.Baker.S, sonographic appearance of the endometrium and ovaries during cycles stimulated with human menopausal gouadotropin. J Reprod Med 1996: 41: 509- 514.##Tomlinson Mj.prognostic indicators for intrauterine insemination (IUI): statistical model for IUI success. Human Reprod 1996; 11:1892-1896.##Hock DL Sonographic assessment of endometrial pattern and thickness in patients treated with CC, HMG and IUI. Fertil Steril 1997; 68: 242-245.##Tsai HD, Change CC, Hsieh YY, Lee CC. lolly. Artificial insemination. Role of ET and patiern, of vascular impedence of the spiral and uterine arteries, and of the dominant follicle. J Reprod Med 2000; 45: 195-200.##Hsieh YY. Low dose aspirin for infertile women with thin endometrium receiving intrauterine insemination: a perspective randomized Study. J Assist Reprod Genet 2000 17: 174-177.##Zollner U. Impact of 3-D measured endometrial volume on the pregnancy rate after IUI. Zentralbi Gynakol 2003; 125: 136-141.##Kolibiianahis E.M.Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for IUI. Reprod Biomed online 2004; 8: 115-118.##Unfer V. High does of phytoestrognes can reverse the antiestrogenic effect of cc on the endometrium in patients undergoing IUI: A randomized trial. J Soc Gynecol Interesting 2004; 11: 323-328##Esmailzadeh, S, Endometrial thickness and pregnancy outcome after IUI. Fertility Sterility 2007 88: 432 – 437.##Merviel. P. Predictive factors for pregnancy after IUI: An analysis of 1038 cycles and a review of the literature. Fertil Steril 2008. Nov 7.##Dickey Rp, olar TT, Taylor SN, Curok DN, Matulich EM. Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: ffect of cc alone and with HMG. Fertil Steril 1993; 59: 756-760.##Wiser Amir M.D .Baum Micha M.D predicting factors for ET during treatment with ART. Fertil Steril 2007; 87: 799-804.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Causes of delay in proper treatment of patients with undescended testis</TitleF>
		<TitleE>بررسی علل تاخیر در درمان به موقع بیماران مبتلا به بیضه نزول نکرده</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه : عدم نزول بیضه، شایعترین اختلال اندوکرین در کودکان مذکرمی باشد که تاخیردر تشخیص و درمان به موقع آن، منجر به عوارضی مانند ناباروری، بدخیمی و چرخش بیضه ها می گردد.
هدف : هدف از این مطالعه، بررسی علل تاخیر در درمان به موقع بیماران مبتلا به بیضه نزول نکرده در جمعیت مورد نظر می باشد.
مواد و روش ها : در این مطالعه مشاهده ای- توصیفی- مقطعی، 143 بیمار مذکر که جهت عمل ارکیوپکسی به بیمارستان شهید صدوقی دانشگاه علوم پزشکی یزد مراجعه کرده بودند، مورد بررسی قرار گرفتند. حداکثر سن پیشنهادی جهت عمل جراحی ارکیوپکسی در این مطالعه 18 ماهگی بود.
نتایج : میانگین سنی بیماران هنگام مراجعه 34/5 سال بود. نتایج حاصل از ارزیابی مطالعه نشان داد که تنها 44 نفر (30/8%) از بیماران قبل از18 ماهگی تشخیص و تحت عمل جراحی قرار گرفتند. شایعترین علت تاخیر در درمان به موقع به ترتیب شامل: عدم تشخیص اولیه توسط پزشکان (42/5%) ، عدم اطلاع والدین در مورد ضرورت عمل جراحی و عوارض آن (33/7%) و بی اطلاعی والدین نسبت به بیماری )23/8%) بود. در این میان تنها 19/6% از بیماران در بدو تولد در بیمارستان توسط پزشکان تشخیص داده شده بودند. 49% والدین آگاهی کافی نسبت به سن مناسب جراحی داشتند و 40/6% از آن ها اطلاعات کافی از ضرورت انجام عمل جراحی و عوارض بیماری داشتند. سطح سواد والدین، محل اقامت بیماران و نوع کریپتورکیدیسم ارتباط معنی داری با علل تاخیر در تشخیص بیماری نداشتند. (0/05p&#62; (
نتیجه گیری : نتایج این مطالعه نشان می دهد که عدم تشخیص اولیه بیماری توسط پزشکان وعدم آگاهی کافی والدین از آن، دلایل اصلی تاخیر در تشخیص و درمان به موقع بیماری می باشند؛ لذا آموزش جامعه بویژه والدین و معاینه دقیق نوزادان در بدو تولد و پیگیری منظم آن ها تا 18 ماهگی می تواند در تشخیص و درمان به موقع بیماری موثر باشد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Undescended testis (UDT) is the most common endocrine disorder in male children. Delayed diagnosis and treatment of UDT lead to complications such as infertility, malignancy and testis rotation.
Objective: The aim of this study was to evaluate the causes of delay in proper treatment of patients with undescended testis in our population.
Materials and Methods: An observational, descriptive, cross sectional study of 143 male patients, who applied to Shahid Sadoughi University Hospitals for orchiopexy operation was performed. The maximum recommended age for orchiopexy was 18 months.
Results: The mean age at referral was 5.34 years. Only 44 (30.8%) cases were operated on before the age of 18 months. The most common reasons of delay in treatment were absence of early diagnose (42.5%),&#160;parent&#39;s unawareness of surgery necessity and its complications associated (33.7%) and&#160;parent&#39;s disregard (23.5%). Only 19.6% of patients were diagnosed at born in the hospital. 49% of parents had the correct information for proper operation age and 40.6% of them had enough information about necessity of surgery and side effects of disease. Parent&#8217;s literacy, place of living and type of cryptorchidism had no significant relation with delay diagnosis (p&#62; 0.05).
Conclusion: These results revealed that late diagnosis by physician and lack of insight of parents are the main reasons in delayed diagnosis and treatment of UDT. Therefore, education of parents and careful physical examination of the babies at birth and regular follow-up until 18 months can prevent the delay in diagnosis.&#160;</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>0</FPAGE>
			<TPAGE>0</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2017/10/12017/10/12017/10/12017/10/12017/10/12017/10/12017/10/1
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/7/9
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2017/10/52017/10/52017/10/52017/10/52017/10/52017/10/52017/10/5
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1396/7/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>سید مصطفی</Name>
				<MidName></MidName>
				<Family>شیریزدی</Family>
				<NameE>Seyyed Mostafa</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Shiryazdi</FamilyE>
				<Organizations>
				<Organization>Department of Surgery, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>smshiryazdi@ssu.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>عباس</Name>
				<MidName></MidName>
				<Family>مدیر</Family>
				<NameE>Abbas</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Modir</FamilyE>
				<Organizations>
				<Organization>Department of Surgery, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>سهیل</Name>
				<MidName></MidName>
				<Family>بن رضوی</Family>
				<NameE>Soheil</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Benrazavi</FamilyE>
				<Organizations>
				<Organization>Department of Surgery, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>نوشین</Name>
				<MidName></MidName>
				<Family>موسوی</Family>
				<NameE>Nooshin</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Moosavi</FamilyE>
				<Organizations>
				<Organization>Department of Surgery, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>محمد</Name>
				<MidName></MidName>
				<Family>کرمانی القریشی</Family>
				<NameE>Mohammad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Kermani-Alghoraishi</FamilyE>
				<Organizations>
				<Organization>Student Research Committee, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>راحیل</Name>
				<MidName></MidName>
				<Family>قهرمانی</Family>
				<NameE>Rahil</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghahramani</FamilyE>
				<Organizations>
				<Organization>Student Research Committee, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Delayed diagnosis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Undescended testis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Orchiopexy</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Infant</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تاخیر در تشخیص</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>بیضه نزول نکرده</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ارکیوپکسی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>کودک</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Kolon TF, Patel RP, Huff DS. Cryptorchidism; diagnosis, treatment and long-term prognosis. Urol Clin N Am 2005; 31: 469-480.##Barthold JS, Gonzales R. The Epidemiology of Congenital Cryptorchidism, Testicular Ascent and Orchiopexy. J Urol 2003; 170: 2396-401.##Virtanen HE, Toppari J. Epidemiology and pathogenesis of cryptorchidism. Hum Reprod Update 2008; 14: 49-58.##Elert A, Jahn K, Heidenreich A, Hofmann R. The familial undescended testis. Klin Padiat 2003; 215: 40-45.##Cisek LJ, Peters CA, Atala A, Bauer SB, Diamond DA, Retik AB. Current findings in diagnostic laparoscopic evaluation of the nonpalpable testis. J Urol 1998; 160: 1145-1149.##Virtanen HE, Bierknes R, Cortes D, Jorgensen N, Rajpert-De Meyts E, Thorsson AV, et al. Cryptorchidism: classification, prevalence and long-term consequences. Acta Paediatr 2007; 96: 611-616##Wang F, Roberts SM, Butfi loski EJ, Sobel ES. Acceleration of autoimmunity by organochlorine pesticides: a comparison of splenic B-cell effects of chlordecone and estradiol in (NZBxNZW) F1 mice. Toxicological Sciences 2007; 99: 141-152.##Docimo SG, Silver RI, Cromie W. The undescended testicle: diagnosis and management. Am Fam Physician 2000; 62: 2037-2044.##Capello SA, Georgi LJ Jr, Kogan BA. Orchiopexy practice patterns in New York State from 1984 to 2002. J Urol 2006; 176: 1180-1183.##Upadhyay V, Kothari M, Manoharan M. The referral pattern for undescended testes in Auckland. NZ Med J 2001; 114: 310-311.##Lamah M, McCaughey ES, Finlay FO, Burge DM. The ascending testis: Is late orchidopexy due to failure of screening or late ascent? Paediatr Surg Int 2002; 17: 421-423.##Hack WW, Meijer RW, VanDer VLM, Bos SD, De Kok ME. Previous testicular position in boys referred for an undescended testis; further explanation of the late orchiopexy enigma? BJU 2003; 92: 293-296.##Thayyil S, Shenoy M, Agrawal K. Delayed orchiopexy: failure of screening or ascending testis. Arch Dis Child 2004; 89: 890.##Brown JJ, Wacogne I, Fleckney S, Jones L, Ni Bhrolchain C. Achieving early surgery for undescended testes: quality improvement through a multifaceted approach to guideline implementation. Child Care Health Dev 2005; 31: 97- 102.##Timing of elective surgery on the genitalia of male children with particular reference to the risks, benefits, and psychological effects of surgery and anesthesia. American Academy of Pediatrics. Pediatrics 1996; 97: 590-594.##United Kingdom Testicular Cancer Study Group. Aetiology of testicular cancer: Association with congenital abnormalities, age at puberty, infertility, and exercise. Br Med J 2008; 308: 1393-1399.##Cortes D, Kjellberg EM, Breddam M, Thorup J. The true incidence of cryptorchidism in Denmark. J Urol 2008; 179: 314-318.##Hadziselimovic F, Huff D. Gonadal differentiation-Normal and abnormal testicular development. Adv Exp Med Biol 2002; 511: 15- 21.##Huff DS, Fenig DM, Canning DA, Carr MG, Zderic SA, Snyder HM. Abnormal germ cell development in cryptorchidism. Horm Res 2001; 55: 11-17.##Guven A, Kogan BA. Undescended testis in older boys: further evidence that ascending testes are common. J Pediatr Surg 2008; 43: 1700-1704.##Davey RB. Undescended testes: early versus late maldescent. Pediatr Surg Int 1997; 12: 165-167.##Cendron M, Huff DS, Keating MA, Snyder HM 3rd, Duckett JW. Anatomical, morphological and volumetric analysis: a review of 759 cases of testicular maldescent. J Urol 1993; 149: 570-573.##Seddon JM, Savory L, Scott-Conner C. Cryptorchidism: the role of medical education in diagnosis. South Med J 1985; 78: 1201-1204.##A Sarmah. Late diagnosis of cryptorchidism: a failure of medical screening? Arch Dis Child 1992; 67: 728–730##Raghavendran M, Mandhani A, Kumar A, Chaudary H, Srivastava A, Bhandari M, Dubey D, Kapoor R. Adult cryptorchidism: Unrevealing the cryptic facts. Indian Journal of Surgery 2004; 66: 160-163.##Steckler RE, Zaontz MR, Skoog SJ, Rushton HG Jr. Cryptorchidism, pediatricians, and family practitioners: patterns of practice and referral. J Pediatr 1995; 127: 948-951.##Sinha CK, Vinay S, Kulkarni R, Nour S. Delayed diagnosis for undescended testes. Indian Pediatr 2008; 45: 503-504.##Rabinowitz R, Hulbert WC Jr. Late presentation of cryptorchidism: the etiology of testicular re-ascent. J Urol 1997; 157: 1892-1894.##Gyawali B, Bhattacharyya S, Reid JA. Medical audit of community screening for undescended testes in Halton District. Public Health 1993; 107: 343-347.##Kolon TF, Patel RP, Huff DS. Cryptorchidism; diagnosis, treatment and long-term prognosis. Urol Clin N Am 2005; 31: 469-480.##Barthold JS, Gonzales R. The Epidemiology of Congenital Cryptorchidism, Testicular Ascent and Orchiopexy. J Urol 2003; 170: 2396-401.##Virtanen HE, Toppari J. Epidemiology and pathogenesis of cryptorchidism. Hum Reprod Update 2008; 14: 49-58.##Elert A, Jahn K, Heidenreich A, Hofmann R. The familial undescended testis. Klin Padiat 2003; 215: 40-45.##Cisek LJ, Peters CA, Atala A, Bauer SB, Diamond DA, Retik AB. Current findings in diagnostic laparoscopic evaluation of the nonpalpable testis. J Urol 1998; 160: 1145-1149.##Virtanen HE, Bierknes R, Cortes D, Jorgensen N, Rajpert-De Meyts E, Thorsson AV, et al. Cryptorchidism: classification, prevalence and long-term consequences. Acta Paediatr 2007; 96: 611-616##Wang F, Roberts SM, Butfi loski EJ, Sobel ES. Acceleration of autoimmunity by organochlorine pesticides: a comparison of splenic B-cell effects of chlordecone and estradiol in (NZBxNZW) F1 mice. Toxicological Sciences 2007; 99: 141-152.##Docimo SG, Silver RI, Cromie W. The undescended testicle: diagnosis and management. Am Fam Physician 2000; 62: 2037-2044.##Capello SA, Georgi LJ Jr, Kogan BA. Orchiopexy practice patterns in New York State from 1984 to 2002. J Urol 2006; 176: 1180-1183.##Upadhyay V, Kothari M, Manoharan M. The referral pattern for undescended testes in Auckland. NZ Med J 2001; 114: 310-311.##Lamah M, McCaughey ES, Finlay FO, Burge DM. The ascending testis: Is late orchidopexy due to failure of screening or late ascent? Paediatr Surg Int 2002; 17: 421-423.##Hack WW, Meijer RW, VanDer VLM, Bos SD, De Kok ME. Previous testicular position in boys referred for an undescended testis; further explanation of the late orchiopexy enigma? BJU 2003; 92: 293-296.##Thayyil S, Shenoy M, Agrawal K. Delayed orchiopexy: failure of screening or ascending testis. Arch Dis Child 2004; 89: 890.##Brown JJ, Wacogne I, Fleckney S, Jones L, Ni Bhrolchain C. Achieving early surgery for undescended testes: quality improvement through a multifaceted approach to guideline implementation. Child Care Health Dev 2005; 31: 97- 102.##Timing of elective surgery on the genitalia of male children with particular reference to the risks, benefits, and psychological effects of surgery and anesthesia. American Academy of Pediatrics. Pediatrics 1996; 97: 590-594.##United Kingdom Testicular Cancer Study Group. Aetiology of testicular cancer: Association with congenital abnormalities, age at puberty, infertility, and exercise. Br Med J 2008; 308: 1393-1399.##Cortes D, Kjellberg EM, Breddam M, Thorup J. The true incidence of cryptorchidism in Denmark. J Urol 2008; 179: 314-318.##Hadziselimovic F, Huff D. Gonadal differentiation-Normal and abnormal testicular development. Adv Exp Med Biol 2002; 511: 15- 21.##Huff DS, Fenig DM, Canning DA, Carr MG, Zderic SA, Snyder HM. Abnormal germ cell development in cryptorchidism. Horm Res 2001; 55: 11-17.##Guven A, Kogan BA. Undescended testis in older boys: further evidence that ascending testes are common. J Pediatr Surg 2008; 43: 1700-1704.##Davey RB. Undescended testes: early versus late maldescent. Pediatr Surg Int 1997; 12: 165-167.##Cendron M, Huff DS, Keating MA, Snyder HM 3rd, Duckett JW. Anatomical, morphological and volumetric analysis: a review of 759 cases of testicular maldescent. J Urol 1993; 149: 570-573.##Seddon JM, Savory L, Scott-Conner C. Cryptorchidism: the role of medical education in diagnosis. South Med J 1985; 78: 1201-1204.##A Sarmah. Late diagnosis of cryptorchidism: a failure of medical screening? Arch Dis Child 1992; 67: 728–730##Raghavendran M, Mandhani A, Kumar A, Chaudary H, Srivastava A, Bhandari M, Dubey D, Kapoor R. Adult cryptorchidism: Unrevealing the cryptic facts. Indian Journal of Surgery 2004; 66: 160-163.##Steckler RE, Zaontz MR, Skoog SJ, Rushton HG Jr. Cryptorchidism, pediatricians, and family practitioners: patterns of practice and referral. J Pediatr 1995; 127: 948-951.##Sinha CK, Vinay S, Kulkarni R, Nour S. Delayed diagnosis for undescended testes. Indian Pediatr 2008; 45: 503-504.##Rabinowitz R, Hulbert WC Jr. Late presentation of cryptorchidism: the etiology of testicular re-ascent. J Urol 1997; 157: 1892-1894.##Gyawali B, Bhattacharyya S, Reid JA. Medical audit of community screening for undescended testes in Halton District. Public Health 1993; 107: 343-347.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Metformin-letrozole in comparison with Metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI</TitleF>
		<TitleE>مقایسه ترکیب متفورمین- لتروزول با متفورمین- کلومیفن سیترات در بیماران با سندرم تخمدان پلی کیستیک مقاوم به کلومیفن که تحت درمان IUI قرار گرفته اند</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: سندرم تخمدان پلی کیستیک در 75% زنان نازا با عدم تخمک گذاری دیده می شود.همچنین حدود 25-20% این بیماران به کلومیفن پاسخ نمی دهند که مقاوم به کلومیفن نامیده می شوند.اختلاف بین میزان تخمک گذاری و حاملگی که با کلومیفن دیده می شود را به اثر آنتی استروژنی آن نسبت میدهند و به همین علت&#160; مهار کننده های آروماتاز بعنوان درمان جایگزین در این بیماران پیشنهاد می گردد.
هدف:مقایسه اثرمتفورمین-لتروزول با متفورمین-کلومیفن در بیماران با سندرم تخمدان پلی کیستیک که تحت IUIقرار می گیرند.
مواد و روش ها:در این کارآزمایی تصادفی یک سوکور100بیمار مقاوم به کلومیفن وارد مطالعه شدند. معیار ورود به مطالعه، بیماران با سندرم تخمدان پلی کیستیک که بعد از دریافت 150میلیگرم کلومیفن روزانه تا سه سیکل حامله نشدند، بود. بیماران از نظر سن، شاخص توده بدنی و مدت نازائی یکسان بودند.بیماران به طور تصادفی به دو گروه متفورمین-لتروزول (50نفر) ومتفورمین-کلومیفن (50نفر) تقسیم و از نظرحاملگی شیمیائی کلینیکی و میزان سقط در دو گروه مقایسه شدند.
نتایج:از نظر میزان حامگی، اختلاف معنی داری بین دو گروه دیده نشد.یک مورد سقط(2%) در گروه متفورمین-کلومیفن دیده شد در حالیکه در گروه متفورمین-لتروزول هیچ مورد دیده نشد.
نتیجه گیری: با وجود اینکه از نظر آماری اختلاف معنی داری در میزان حاملگی دو گروه کلومیفن و لتروزول بدست نیامد ولی میزان آن در گروه اول 2% و درگروه دوم 5%بوده است.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Polycystic ovary syndrome (PCOS) is associated with approximately 75% of women who suffer from infertility due to anovulation. Additionally, around 20&#8211; 25% of anovulatory women with PCOS do not respond at all to clomiphene citrate and are considered to be &#8220;clomiphene&#8211; resistant&#8221;. Aromatase inhibitors have been suggested as an alternative treatment to clomiphene as the discrepancy between ovulation and pregnancy rates with clomiphene citrate has been attributed to its anti-estrogenic action and estrogen receptor depletion.
Objective: The aim of this study is to compare results of Metformin-letrozole with Metformin-clomiphene citrate in clomiphene resistance PCOS patients undergoing IUI.
Materials and Methods: In this single blind randomized trial, ovarian cycles were studied in 100 clomiphene- resistant patients with PCOS. The inclusion criteria were patients who received 150mg clomiphene citrate daily for 3 cycles and failed to become pregnant. The patients were matched for their age, body mass index (BMI), and infertility period. They were randomly allocated to a metformin-letrozole group (n=50) and a metformin-clomiphene citrate group (n=50). Chemical and clinical pregnancies were assessed after IUI. Abortion rates were determined in both groups.
Results: Regarding pregnancy rate, there was no significant difference between the two groups. One miscarriage (2%) occurred in the metformin-clomiphene citrate group, whereas none was seen in the metformin-letrozole group.
Conclusion: There is no significant difference in pregnancy rate between clomiphene citrate and letrozole groups although it has been 2% in the former and 5% in the latter. Article</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>0</FPAGE>
			<TPAGE>0</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2017/10/12017/10/12017/10/12017/10/12017/10/12017/10/12017/10/12017/10/1
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/7/9
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2017/10/52017/10/52017/10/52017/10/52017/10/52017/10/52017/10/52017/10/5
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1396/7/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>رباب</Name>
				<MidName></MidName>
				<Family>داور</Family>
				<NameE>Robab</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Davar</FamilyE>
				<Organizations>
				<Organization>Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>r_davar@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>مژگان</Name>
				<MidName></MidName>
				<Family>جاودانی</Family>
				<NameE>Mojgan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Javedani</FamilyE>
				<Organizations>
				<Organization>Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>محمد حسین</Name>
				<MidName></MidName>
				<Family>فلاح زاده</Family>
				<NameE>Mohammad Hossein</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Fallahzadeh</FamilyE>
				<Organizations>
				<Organization>Department of Biostatistics and Epidemiology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Letrozole</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Clomiphene citrate</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Ovarian stimulation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>PCO</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>IUI</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Metformin</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>لتروزول</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>کلومیفن سیترات</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تحریک تخمدان</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تخمدان پلی کیستیک</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>IUI</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>متفورمین</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Gordon P, Treasure JL, King EA, Wheeler M, Russell GF. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) 1986; 293: 956-957.##Hull MG. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1987; 1: 235-245.##Gysler M, March CM, Mishell DR Jr, Bailey EJ. A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test. Fertil Steril 1982; 37: 161-167.##Macgregor AH, Johnson JE, Bunde CA. Further clinical experience with clomiphene citrate. Fertil Steril 1968; 19: 616-622.##Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC. A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril 2002; 77: 91-97.##Franks S, Hamilton-fairley D. Ovulation Induction: Gonadotrophins. In: Reproductive Endocrinology, Surgery and Technology 1996; Philadelphia, Lippincott-Raven.##Imani B, Eijkemans MJ, TE Velde ER, Habbema JD, Fauser BC. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 1998; 83: 2361-2365.##Hakim RB, Gray RH, Zacur H. Infertility and early pregnancy loss. Am J Obstet Gynecol 1995; 172: 1510-1517.##Check JH, Dietterich C, Lurie D. The effect of consecutive cycles of clomiphene citrate therapy on endometrial thickness and echo pattern. Obstet Gynecol 1995; 86: 341-345.##Gonen, Y, Casper RF. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 1990; 5: 670-674.##ben-ami M, Geslevich Y, Matilsky M, Battino S, Weiner E, Shalev E. Exogenous estrogen therapy concurrent with clomiphene citrate--lack of effect on serum sex hormone levels and endometrial thickness. Gynecol Obstet Invest 1994; 37: 180-182.##Nelson LM, Hershlag A, Kurl RS, Hall JL, Stillman RJ. Clomiphene citrate directly impairs endometrial receptivity in the mouse. Fertil Steril 1990; 53:727-731.##LI TC, Warren MA, Murphy C, Sargeant S, Cooke IDA. Prospective, randomised, cross-over study comparing the effects of clomiphene citrate and cyclofenil on endometrial morphology in the luteal phase of normal, fertile women. Br J Obstet Gynaecol 1992; 99: 1008-1013.##Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001; 75: 305-309.##Mitwally MF, Casper RF. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril 2002b; 77: 776-780.##Mitwally MF, Casper RF. Single-dose administration of an aromatase inhibitor for ovarian stimulation. Fertil Steril 2005; 83: 229-231.##Mitwally MF, Biljan MM, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 2005; 192: 381- 386.##AL-Fozan H, AL-Khadouri M, Tan SL, Tulandi TA. Randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril 2004; 82: 1561-1563.##Fisher SA, Reid RL, Van vugt DA, Casper RF. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril 2002; 78: 280-285.##Sammour A, Biljan MM, Tan SL, Tulandi T. Prospective randomized trial comparing the effects of letrozole and clomiphene citrate on follicular development, endometrial thickness, and pregnancy rate in patients undergoing superovulation prior to intrauterine insemination. Fertil Steril 2001; 76: S110.##Mitwally MF, Casper RF. Aromatase inhibition for ovarian stimulation: future avenues for infertility management Curr Opin Obstet Gynecol 2002a; 14: 255-263.##Fleming R, Hopkinson ZE, Wallace AM, Greer IA, Sattar N. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab 2002; 87:569-574.##Heard MJ, Pierce A, Carson SA, Buster JE. Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome. Fertil Steril 2002; 77: 669-673.##Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998; 338: 1876-1880.##Bast RC, Kufe DW, Pollock RE, Weichselbaum RR. Cancer Medicine: abnormal mammogram.5th edition. Holland: Hamilton; 2000.##Sohrabvand F, Ansari S, Bagheri M. Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Hum Reprod 2006; 21: 1432-1435.##David K Gardner,ArielWeissman, Colin M Howles, Zeev Shoham. Textbook of assisted reproductive technologies. 3rd Ed. United Kingdom; Informa Healthcare; 2009.##Gordon P, Treasure JL, King EA, Wheeler M, Russell GF. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) 1986; 293: 956-957.##Hull MG. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1987; 1: 235-245.##Gysler M, March CM, Mishell DR Jr, Bailey EJ. A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test. Fertil Steril 1982; 37: 161-167.##Macgregor AH, Johnson JE, Bunde CA. Further clinical experience with clomiphene citrate. Fertil Steril 1968; 19: 616-622.##Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC. A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril 2002; 77: 91-97.##Franks S, Hamilton-fairley D. Ovulation Induction: Gonadotrophins. In: Reproductive Endocrinology, Surgery and Technology 1996; Philadelphia, Lippincott-Raven.##Imani B, Eijkemans MJ, TE Velde ER, Habbema JD, Fauser BC. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 1998; 83: 2361-2365.##Hakim RB, Gray RH, Zacur H. Infertility and early pregnancy loss. Am J Obstet Gynecol 1995; 172: 1510-1517.##Check JH, Dietterich C, Lurie D. The effect of consecutive cycles of clomiphene citrate therapy on endometrial thickness and echo pattern. Obstet Gynecol 1995; 86: 341-345.##Gonen, Y, Casper RF. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 1990; 5: 670-674.##ben-ami M, Geslevich Y, Matilsky M, Battino S, Weiner E, Shalev E. Exogenous estrogen therapy concurrent with clomiphene citrate--lack of effect on serum sex hormone levels and endometrial thickness. Gynecol Obstet Invest 1994; 37: 180-182.##Nelson LM, Hershlag A, Kurl RS, Hall JL, Stillman RJ. Clomiphene citrate directly impairs endometrial receptivity in the mouse. Fertil Steril 1990; 53:727-731.##LI TC, Warren MA, Murphy C, Sargeant S, Cooke IDA. Prospective, randomised, cross-over study comparing the effects of clomiphene citrate and cyclofenil on endometrial morphology in the luteal phase of normal, fertile women. Br J Obstet Gynaecol 1992; 99: 1008-1013.##Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001; 75: 305-309.##Mitwally MF, Casper RF. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril 2002b; 77: 776-780.##Mitwally MF, Casper RF. Single-dose administration of an aromatase inhibitor for ovarian stimulation. Fertil Steril 2005; 83: 229-231.##Mitwally MF, Biljan MM, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 2005; 192: 381- 386.##AL-Fozan H, AL-Khadouri M, Tan SL, Tulandi TA. Randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril 2004; 82: 1561-1563.##Fisher SA, Reid RL, Van vugt DA, Casper RF. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril 2002; 78: 280-285.##Sammour A, Biljan MM, Tan SL, Tulandi T. Prospective randomized trial comparing the effects of letrozole and clomiphene citrate on follicular development, endometrial thickness, and pregnancy rate in patients undergoing superovulation prior to intrauterine insemination. Fertil Steril 2001; 76: S110.##Mitwally MF, Casper RF. Aromatase inhibition for ovarian stimulation: future avenues for infertility management Curr Opin Obstet Gynecol 2002a; 14: 255-263.##Fleming R, Hopkinson ZE, Wallace AM, Greer IA, Sattar N. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab 2002; 87:569-574.##Heard MJ, Pierce A, Carson SA, Buster JE. Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome. Fertil Steril 2002; 77: 669-673.##Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998; 338: 1876-1880.##Bast RC, Kufe DW, Pollock RE, Weichselbaum RR. Cancer Medicine: abnormal mammogram.5th edition. Holland: Hamilton; 2000.##Sohrabvand F, Ansari S, Bagheri M. Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Hum Reprod 2006; 21: 1432-1435.##David K Gardner,ArielWeissman, Colin M Howles, Zeev Shoham. Textbook of assisted reproductive technologies. 3rd Ed. United Kingdom; Informa Healthcare; 2009.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>A case report of spontaneous pregnancy during hormonal replacement therapy for premature ovarian failure</TitleF>
		<TitleE>گزارش یک مورد بارداری خود بخودی در حین درمان جایگزینی هورمونی در بیمار مبتلا به نارسایی زودرس تخمدانی</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه:نارسایی زودرس تخمدان یک بیماری شایع است. شیوع این بیماری 1 در&#160;&#160; 100 زن در سنین قبل از 40 سالگی می باشد. هورمون درمانی تا شروع سنین معمول یائسگی گزینه مناسبی در این بیماران میباشد. برگشت موقت فعالیت تخمدان ها در این بیماران گزارش شده است. حاملگی یک پدیده بسیار نادر در بیماران بانارسایی زودرس تخمدان است. دراینجا ما یک مورد حاملگی خود بخود در بیمار مبتلا به نارسایی زود رس تخمدان&#160; را معرفی می نماییم.
مورد:یک زن نازا 30 ساله با بیماری نارسایی زودرس تخمدان اثبات شده، به دنبال جراحی لگنی و استرس هیجانی شدید به صورت خودبخودباردار شده است.
نتیجه گیری:برگشت عملکرد تخمدان و بروز حاملگی در زنان با نارسایی زودرس تخمدان امکان پذیر می باشد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Premature ovarian failure (POF) is a common condition; its incidence is estimated to be as great as 1 in 100 by the age of 40 years. Physiologic replacement of ovarian steroid hormones seems rational until the age of normal menopause. Temporary return of ovarian function and pregnancy may occur rarely in women with POF. We report a case of POF who conceived during hormone replacement therapy.
Case: A 30 years-old woman with confirmed POF after pelvic surgery and sever emotional stress conceived spontaneously.
Conclusion: Return of ovarian function and achievement of pregnancy is possible in women with POF.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>0</FPAGE>
			<TPAGE>0</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2017/10/12017/10/12017/10/12017/10/12017/10/12017/10/12017/10/12017/10/12017/10/1
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/7/9
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2017/10/52017/10/52017/10/52017/10/52017/10/52017/10/52017/10/52017/10/52017/10/5
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1396/7/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>فیروزه</Name>
				<MidName></MidName>
				<Family>اکبری اسبق</Family>
				<NameE>Firoozeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Akbari Asbagh</FamilyE>
				<Organizations>
				<Organization>Department of Obstetrics and Gynecology, Mirza Koochak Khan Hospital, Faculty of Medicine, Tehran University, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>F.AsbaghM.D@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>مهبد</Name>
				<MidName></MidName>
				<Family>ابراهیمی</Family>
				<NameE>Mahbod</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ebrahimi</FamilyE>
				<Organizations>
				<Organization>Department of Obstetrics and Gynecology, Mirza Koochak Khan Hospital, Faculty of Medicine, Tehran University, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Premature ovarian failure</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Transient ovarian failure</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Hypergonadotropic hypogonadism</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Hypergonadotropic amenorrhea</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Hormone replacement</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>نارسایی زودرس تخمدان</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>نارسایی موقت تخمدان</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>هیپوگنادیسم هیپوگنادوتروپیسم</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>آمنوره هیپرگنادوتروپیسم</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>هورمون درمانی</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Conway GS. Premature ovarian failure. Br Med Bull. 2000; 56: 643-498.##Luborsky JL. Meyer P, Sowers MF, Gold EB. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod 2003; 18: 199-206.##Laml T, Schulz-Lobmeyr I, Obbruca A, Huber JC, Hartmann BW. Premature ovarian failure: etiology and prospects. Gynecol Endocrinol 2000; 14: 292-302.##Pal L, Santoro N, Premature ovarian failure (POF): discordance between somatic and reproductive aging. Res Rev 2002; 1: 413-423.##Netter A, Lambert A, Lumbroso P. Etudes sur les amenorrhees. Les amenorrhees ovariplegiques. Bull Mem Soc Hop Paris 1958; 74: 248-250.##Panay N, Kalu E. Management of premature ovarian failure. Best Practice and Research Clinical Obstet Gynecol 2009; 23: 129-140.##Goswami D, Conway GS, Premature ovarian failure. Hum Reprod update 2005; 11: 391-410.##Van Kasteren YM. Treatment concepts for premature ovarian failure. J Soc Gynecol Investig 2001; 8: S58-59.##Anassti JN. Premature ovarian failure: an update. Fertil Steril 1998; 70: 1-15.##Sayegh R, Garcia CR. Ovarian function after conservational ovarian surgery: a long-term follow-up study. Int J Gynecol Obstet 1992; 39: 303-309.##Donnez J, Squifflet J, Van Eyck AS. Restoration of ovarian function in orthotopically transplanted cryopreserved ovarian tissue: a pilot experience. Reprod Biomed on line. 2008; 16: 694-704.##Huang JY, Tulandi T,Holzer H. Combining ovarian tissue crobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril 2008; 69: 567-572.##Hefler L A, Grimm C, Bentz EK, A model for predicting age at menopause in white women. Fertil Steril 2006; 65: 451-454.##Broekmans FJ, Kwee J, Hendriks DJ. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod update 2006; 12: 685-718.##Corrigan EC, Raygada MJ, Vanderhoof VH, Lawrence M, Neison LM. A woman with spontaneous premature ovarian failure gives birth to a child with fragile X syndrome. Fertil Steril 2005, 84: 1508.e 5-8.##Keegan DA, Krey LC, Noys N. Younger ( ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>

</ARTICLES>

</JOURNAL>
</XML>
